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ABSTRACT OF DISSERTATION

PROMOTION OF EARLY PEDIATRIC HEARING DETECTION THROUGH
PATIENT NAVIGATION
Congenital hearing loss is the most common neonatal sensory disorder and it is
crucial to diagnose hearing loss as soon as possible after birth in order to facilitate rapid
treatment. Universal standards of infant hearing healthcare dictate that infant hearing
screening should be completed by one month of age and abnormal screening tests
should be followed with definitive audiological testing by three months of age. Obtaining
diagnostic testing can be complicated by limited access to care in rural areas,
breakdowns in communication, lack of parental support, and poor coordination of care.
There is no established method to address appointment non-adherence in newborn
hearing testing. Patient navigation (PN), which uses trained healthcare workers to
educate patients and facilitate adherence to healthcare, is an evidence-based approach
that has had widespread success in facilitating timely care in other healthcare settings
but has not been studied in infant hearing testing. The objective of this dissertation is to
1) assess the effect of patient navigation on care delivery in healthcare inequity settings,
2) assess the efficacy of a PN intervention to decrease non-adherence to recommended
infant audiological testing after failed newborn hearing screening, and 3) develop a
method to implement patient navigation into the state hearing screening program.
The original concept and development of PN stems from the findings of the
American Cancer Society National Hearings on Cancer in the Poor in 1989, which
revealed a host of barriers that underserved populations face in receiving timely and
appropriate, care. Cancer treatment centers have utilized patient navigators (PNs) to
address these barriers in the delivery of cancer care. In order to consider the potential of
applying patient navigation in promoting timely infant hearing healthcare, a systematic
review was performed to systematically assess the efficacy of patient navigation to
improve diagnosis and treatment of diseases affecting medically underserved
populations. Specific outcomes assessed in the review included the effect of PN on
timing of definitive diagnosis and effect on initiation of treatment. The search strategy
produced 1,428 articles and 16 were included for review. In the Oncology field, timing of
initial contact with a patient navigator after diagnostic or screening testing was correlated
to the effectiveness of the navigator intervention. The majority of the studies reported
significantly shorter time intervals to diagnosis and to treatment with patient navigation.
This review provided evidence to justify a PN efficacy trial in infant hearing healthcare.

To investigate the efficacy of PN to decrease non-adherence to recommended
infant audiological testing after failed newborn hearing screening, a randomized
controlled trial was conducted in sixty-one guardian-infant dyads. All infants had
abnormal newborn hearing screening and were recruited within the first week after birth.
Dyads were randomized into a PN study arm or standard of care arm. PN was found to
be efficacious as the percentage of participants with follow-up non-adherence was
significantly lower in the PN arm compared with the standard of care arm (7.4% versus
38.2%, p=0.005). The timing of initial follow-up was significantly lower in the PN arm
compared with the standard of care arm (67.9 days versus 105.9 days, p=0.010). Based
on this efficacy data, the next objective of the research was to scale up PN to maximize
public health impact by combining an effectiveness trial with implementation research. A
hybrid effectiveness/implementation study was designed to investigate patient navigation
within the state-funded EHDI (early hearing detection and intervention) system. Using a
stepped wedge design this trial investigates the 1) effectiveness of PN to decrease nonadherence to hearing testing, 2) implementation factors using the Consolidated
Framework of Implementation Research (CFIR), and 3) cost-effectiveness and
sustainability of a PN program within a state-supported EHDI system.
KEYWORDS: Hearing Loss, Patient Navigation, Healthcare Disparity
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CHAPTER ONE: PEDIATRIC HEARING HEALTHCARE DISPARITIES AND
PATIENT NAVIGATION

1.1 PEDIATRIC HEARING LOSS: A PUBLIC HEALTH CONCERN
As the most common neonatal sensory disorder in the United States, infant
hearing loss occurs in 1.6 per 1000 births.1 The sense of hearing is vital and early
childhood hearing loss can result in lifelong learning delay and disability. The
consequences of delayed infant hearing loss diagnosis and intervention include
significant delays in language, cognitive, and social development2 with profound effects
on education and employment.3 The economic costs of hearing loss are substantial and,
according to the Centers for Disease Control, the overall lifetime medical, educational,
and occupational costs due to deafness for children born in 2000 is estimated to be $2.1
billion.4

1.2 DIAGNOSTIC DELAYS IN PEDIATRIC HEARING LOSS
The United States Preventive Services Task Force recognizes that early
diagnosis of hearing loss leads to decreases in language development problems, social
and emotional challenges, and learning and behavioral disorders.5 Intervention for
hearing loss prior to 6 months of age has profound effects on language expressive
measures and social adjustment.6,7 To promote early diagnosis and treatment, all infants
should be screened no later than 1 month after birth, diagnosis of hearing loss should
occur before 3 months of age, and hearing loss treatment should occur before 6 months
of age (1-3-6 rule).8-11 The Joint Committee on Infant Hearing (JCIH) gold standard is that
no more than 10% of infants would be non-adherent to diagnostic testing by 3 months of
age;12 however, this standard is not being met. In 2014, 58.9% of U.S. infants failed to
obtain a diagnosis within 3 months after abnormal screening.1 In spite of efforts to closely
1

document follow-up and promote adherence to timely testing in Kentucky, the state’s nonadherence rate is still 25.9%, nearly 3 times the JCIH goal.1 In addition, children from
underserved rural regions such as Appalachia are consistently delayed in diagnosis and
treatment of hearing loss.13-15

1.3 FACTORS LEADING TO DIAGNOSTIC DELAYS
Timely adherence to infant diagnostic testing and hearing loss treatment is a
complex process and parents face many barriers. Early infant hearing detection and
intervention (EHDI) programs are coordinated by each state and the diagnostic and
treatment process is complex. Despite multiple streamlining initiatives, many parents find
the diagnostic process and treatment difficult to navigate.16 Risk of non-adherence is
higher in families with greater travel distances, low levels of parental education, low
socioeconomic status, and public insurance.17-20 Families of children with hearing loss
report that they lack confidence and resources needed for healthcare decision-making for
their child.21 Many parents lack role models who have been through the complex process
of hearing loss diagnosis and intervention22 because more than 90% of deaf children
have hearing parents.23 Consistent with the tenets of Social Cognitive Theory (SCT),24-27
a complex interaction of personal, interpersonal, and environmental factors influences
hearing healthcare adherence and access.

1.4 LACK OF EVIDENCE-BASED APPROACHES TO DECREASE INFANT HEARING
DIAGNOSTIC NON-ADHERENCE
There are no existing evidence-based approaches to decrease non-adherence to
infant hearing testing and treatment. Tele-audiology may expand access but requires
significant resources, and insufficient data are available to support widespread use of this
strategy.28 Prenatal educational modules29 and social worker counseling30 have not
2

demonstrated significant benefit in promoting rescreening after failed infant hearing
screening; however, parental contact after postnatal hospital discharge may promote
rescreening.31 Parent-to-parent programs, such as Guide By Your Side,32 are available in
many states and may reduce parental isolation and boost parental acceptance of the
child’s condition.22 However, despite promising data from nearly 2 decades ago, these
programs are not consistently integrated into state-funded EHDI services and diagnostic
centers, and when provided they are under-utilized. Additionally, these programs typically
require the parents to make initial contact to establish services, and they often are not
utilized until after a diagnosis of hearing loss is made. Evidence regarding the effects and
optimal implementation of these programs is lacking; in fact, a recent meta-analysis found
no literature addressing the effectiveness or cost of initiatives designed to
decrease non-adherence in follow-up after failed newborn hearing screening.33

1.5 THE POTENTIAL OF PATIENT NAVIGATION TO PROMOTE INFANT HEARING
ADHERENCE
PN programs can increase healthcare adherence and improve access to care,
especially in underserved rural populations. PNs are trained healthcare workers who
assess and mitigate personal, interpersonal, and environmental barriers to healthcare
adherence and access, consistent with SCT-based approaches to promote healthy
behaviors.24-27 PNs educate patients on health conditions and healthcare systems while
facilitating adherence to healthcare recommendations.34 Primarily implemented and
studied in the cancer field, PN reduces medical non-adherence and hastens diagnosis
and treatment.35-37 PN programs have been especially effective in assisting patients from
traditionally underserved backgrounds, including rural Appalachia.38-45 The positive
patient-level effects of PN (i.e., improved adherence with medical diagnostic testing4648

and timely diagnosis and treatment39,46,49) can resulted in significant healthcare cost
3

savings.45 In order to consider the potential for patient navigation in promoting timely
infant hearing healthcare, it is necessary to obtain a deeper understanding of the role that
patient navigation has played in healthcare promotion in underserved populations.

1.6 PATIENT NAVIGATION IN THE MEDICALLY UNDERSERVED: A SYSTEMATIC
REVIEW
1.6.1 Introduction
Patient adherence to physician recommended follow-up and treatment plans is
often a challenge. Martin et al reported in 2005 that up to 40% of patients did not comply
with their recommended treatment plans. When a patient’s treatment plan is more
complex or requires active lifestyle changes, that percentage of non-adherence can rise to
as high as 70%. Such lack of patient compliance can lead to significant complications in
the patient’s healthcare as well as increased medical expenses.50 Reported factors that
lead to non-adherence include misunderstanding the recommended follow-up or treatment
plan, lack of consistency in the patient’s medical care, cultural or health beliefs that conflict
with the plan, socioeconomic status, mistrust of the healthcare system, and a lack of social
support for the patient.51 All of these factors serve as potential barriers that doctors,
nurses, and other providers must assist the patient in overcoming.
Patient navigation is an evidence-based intervention created to address nonadherence and help patients maneuver through personal and systematic barriers in order
to achieve timely follow-up care for health conditions.52 The role of a patient navigator is to
assist patients in overcoming challenges that prevent adherence to their healthcare plan,
allowing them to timely and adequate treatment. The original concept and development of
this intervention stems from the findings of the American Cancer Society National
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Hearings on Cancer in the Poor in 1989. These hearings revealed a host of difficulties that
underserved populations face in receiving timely and appropriate care. Based on these
findings, Dr. Harold Freeman initiated the first patient navigation program in 1990 to
promote timely cancer treatment in Harlem, New York.53 Since that pilot program,
treatment centers worldwide have been using patient navigators to improve the quality and
timeliness of therapy in a multitude of cancer types. The purpose of this research is to
systematically evaluate the efficacy of patient navigation in improving timely and
appropriate diagnosis and treatment of disease in medically underserved populations. We
hypothesize that patient navigation is effective in improving timely, appropriate follow-up
care for diagnosis and treatment of chronic illness within underserved populations.
1.6.2 Methods
This study was exempt from Institutional Review Board approval. The Preferred
Reporting Items for Systematic Reviews and Meta-Analysis54 checklist was used to guide
this systematic review. A specific outcome measure was not required for inclusion in this
review. The specific inclusion criteria included: 1) articles pertaining to patient navigation in
the healthcare setting, 2) articles reporting on the effect of navigation on definitive
diagnosis, and 3) articles reporting on the effect of navigation on timely initiation of
treatment, and 4) articles studying patient population designated as underserved.
Exclusion criteria included: 1) single case reports or non-original research and 2) language
other than English.
Search Strategy: To perform a systematic literature review of patient navigation in
the underserved, a search string was developed to include patient navigation or similar
programs used in populations that are medically underserved.

A search string was

designed to include studies that addressed both (1) patient navigation and (2) medically
underserved populations. See FIGURE 1.1 for the complete search string. A search
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strategy was developed using The National Library of Medicine’s (NLM) medical subject
heading (MeSH) browser in expanded concept view to identify MeSH indexed search
terms (http://www.nlm.nih.gov/ mesh/MBrowser.html). In an attempt to capture articles
pertaining to the study objective, MeSH terms associated with “patient navigation” were
used to ensure that pertinent navigation studies were not excluded based on the title of
the program. These included barefoot doctors, community health workers, community
health aides, and health promoter. To identify all relevant articles related to “health
disparity” the following words were also included: inequality, low-income, poverty, and
indigent. An initial search was performed in PubMed. [All Fields] was selected to ensure
that articles that mentioned the pertinent terms in any form would be captured. The search
was confined to English only papers. The same search string was then used to search
MEDLINE, PsychINFO, Web of Science, and CINAHL, with duplicates from the four
searches being removed. Title and abstract reviews were conducted to select articles that
dealt with human participants and any form of patient navigation and health disparity,
eliminating case studies, literature reviews, or studies with no reported timing to diagnosis
or treatment outcomes. The search was performed in August 2015. FIGURE 1.1 lists
terms utilized in the search string as well as the algorithm for inclusion/exclusion.
Data Extraction: Article titles and abstracts were reviewed independently by 2
reviewers and were selected or removed based on the inclusion and exclusion criteria. In
the event of disagreement over inclusion, the article was included for full text review to be
more inclusive. A full-text review of all eligible articles was completed independently by the
reviewers and the bibliographies of these articles were examined to identify additional
articles. The two reviewers independently analyzed the articles and results were then
organized into two tables focusing on the outcomes of (1) effect of navigation on obtaining
a definitive diagnosis following screening test and (2) effect of navigation on obtaining

6

FIGURE 1.1 – Preferred reporting items for systematic review and meta-analysis
algorithm

7

treatment following diagnosis. The level of evidence of each article was also assessed
according to the Oxford Centre for Evidence-based Medicine guidelines.55
Bias Assessment: Articles were reviewed independently and scored based on
accepted bias assessment tools. Randomized controlled studies were analyzed using the
National Institute of Health Quality Assessment Tool for Controlled Intervention Studies. A
score was obtained based on the 14-point questionnaire. The authors agreed on a score
of 10 or above for a low risk of bias, 6-9 for a moderate risk of bias and 5 or less for high
risk of bias. Retrospective studies were assessed using the Newcastle – Ottawa Scale.56
The authors agreed on a score of greater than 8 as a low risk for bias, 5-8 for moderate
risk and less than 5 as high risk of bias. Studies that did not conform to these bias scales
were not assessed.
1.6.3 Results
Search Results: The initial search of all 4 databases yielded 1,428 articles. After
the duplicates were removed, 711 articles remained. The titles and abstracts of these
articles were scanned to determine if they met the study objectives; 683 articles were
removed through this process. A full text review and scan of the references of the
remaining twenty-eight articles were performed. Of the twenty-eight, sixteen met the
inclusion criteria and were eligible for the systematic review. All studies were from the
field of Oncology. Of these studies, seven used a randomized trial design, five used a
non-randomized design, two were observational, and two included multiple study sites that
use different methods. There was a lack in consistency in outcome reporting and
intervention conditions, thus a meta-analysis was not performed. The type of navigator in
each study differed; seven of the studies recruited lay people to be trained in the role of a
navigator, three employed nurses with oncology experience, and six studies used a team
approach consisting of a lay person and a nurse or an individual with a master’s in social
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work (MSW). The studies were conducted from 1998-2011, and all were based in the
United States. The participants in the studies included uninsured, non-English speaking,
and underserved residents from urban or rural locations. The reported efficacy of
navigation on diagnosis and treatment are recorded in TABLE 1.1 and TABLE 1.2,
respectively, along with description of the study sample.
Studies with Time to Diagnosis as the Primary Outcome: Fifteen of the articles
included in the review assessed the effect of patient navigation on timely diagnostic
resolution following an abnormal cancer screening. The studies varied regarding the
cancer type included in the trial; six of the articles addressed only patients with abnormal
breast cancer screenings, one involved cervical cancer, one involved colorectal cancer,
and the remaining seven included multiple types of cancer including breast, cervical,
colorectal, and prostate cancers. Diagnostic resolution was defined as a patient obtaining
follow-up testing that resulted in either a definitive diagnosis of cancer or no cancer.57,58 A
majority of the studies measured time to diagnosis as the date of the abnormal screening
to the date diagnostic testing was complete.51,52,57,59-63 Three of the studies placed more
emphasis on adherence to follow-up appointments; however, these appointments usually
resulted in diagnostic resolution as well.59,64,65
As mentioned previously, the qualifications and characteristics of the navigators
varied between studies. Some utilized lay navigators who had personal experience with
the disease and represented the population they were serving (e.g. Hispanic women
serving as navigators in an area where majority of the patients were also Hispanic).
Others reported hiring professional health care workers or MSWs to perform navigation
activities. Some studies included one or more navigators who were bilingual, commonly
speaking English and Spanish. The structure of navigation also varied across studies.
While some used a highly structured guide or assessment tool for each patient encounter,
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others used a simple logging system to record barriers or problems addressed during a
conversation with the patient. Though the execution of navigation differed between the
articles, the basic services provided and challenges addressed were consistent. The
articles cited obstacles such as transportation difficulty, lack of insurance, poor
coordination

of

healthcare

appointments,

language

barriers,

and

general

misunderstanding of the follow-up process as difficulties that navigators helped patients
overcome.
Fourteen of the articles reported significant improvement in obtaining diagnostic
resolution when a navigator was utilized.51,52,57-67 The remaining article did not find the
use of a patient navigator to be effective in improving the time from screening to
diagnosis.68 This outlying study reported a significant gap between the screening test and
contact with the patient navigator. Over one-third of the patients in that study were not
contacted by the navigator within the first month following the abnormal screening test.68
This suggests that timeliness of initial contact by the navigator may influence the efficacy
of such a program. Another study reported earlier diagnostic resolution with navigation;
however, there was no significant difference in cancer stage at time of diagnosis between
the navigator group and the control group in those patients that were actually diagnosed
with cancer.67
Studies with Time to Treatment as Primary Outcome: Four of the sixteen articles
included in this review assessed the effect of a patient navigator on time from definitive
diagnosis to initiation of appropriate treatment. Three of these studies only included
patients diagnosed with breast cancer; the remaining study included patients who had
been diagnosed with breast, cervical, colorectal, and prostate cancers. Two of the studies
utilized a non-randomized design, one used an observational design, and one utilized
multiple designs to accommodate the needs to each site in their study. These articles
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also had the same variation in the characteristics and qualifications of their navigators as
the studies that focused on time to diagnosis, ranging from laypersons to nurses or
MSWs. Each of the studies defined time to treatment initiation as the time from date of
definitive diagnosis to the date that treatment was first received.59,60,69,70 Types of
treatment that were included were radiation, chemotherapy, hormone therapy, and
surgery.69 All four articles saw a significant decrease in time to treatment initiation or
improvement of adherence in the navigated patients over the standard of care.
1.6.3 Discussion
Patient compliance to care is a factor that limits the efficacy of all aspects of
medicine. Within the medically underserved, groups that have limited access to
healthcare, this is an even larger problem. Patient navigation programs are designed to
assist patients, specifically ones from underserved populations, in receiving and
maintaining timely and adequate health care. The studies in this review assessed the
efficacy of patient navigation in assisting the medically underserved in overcoming
barriers to their care. All reports came from the field of Oncology. Review of these
articles yielded themes as to what makes a successful navigation program and which
patients may benefit most from such programs. First, timeliness of navigation initiation
plays a role in the success of a program. The non-efficacious program consistently took
longer to enroll patients into the treatment arm of the study. This suggests that future
navigation programs would benefit their patients by beginning to navigate those patients
as soon after an abnormal screening test as possible. These authors suggest that this
would make the patient-to-navigator relationship more meaningful, and increase the
likelihood that the patient will receive diagnostic resolution and treatment within the
necessary timeframe.68
The risk of malignant disease on screening testing may have an inverse
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relationship with patient navigation efficacy. When screening-testing results revealed a
high risk for cancer patient navigation was less effective as it is likely that key providers of
care play an active role in expediting diagnostic evaluation. However, patients with low or
moderate risk of a cancerous lesion on screening testing yielded the highest efficacy
when navigated versus the control group.62,63 This is proposed to be due to the perceived
importance of definitive diagnostic evaluation.62,63 A navigator may be able to emphasize
the importance of definitive diagnostic evaluation in spite of low to moderate risk of
disease, increasing their rates of adherence to care over control groups. While all
patients from diverse backgrounds benefit from navigation compared with control groups
in these studies, programs with limited resources may see the highest efficacy when
targeting resources towards this specific patient group.
This review found that patient navigation is an efficacious intervention to improve
adherence to receive timely medical care. This is an important issue within Oncology, as
decreasing time to diagnosis and time to treatment has been shown to decrease
mortality. Huo et al. found that delays in diagnosis among breast cancer patients
correlated to increased likelihood of cancer metastasis and lower rates of disease-free
survival.70 Redaniel et al. describe that the patients receiving colorectal cancer screening
sooner after diagnosis have higher survival rates.71 Similarly, Dolly et al. found that a
delay between diagnosis and treatment in endometrial cancer patients was correlated
with higher disease mortality.72 Although disease survival and treatment outcomes were
not consistently reported in the studies within this review, patient navigation expedites
diagnosis and treatment in oncology patients and has the potential to impact survival in
the treatment of cancer. The cost of navigation was underreported in the studies reviewed
and this issue remains a concern when considering wide implementation of such
interventions. In spite of demonstrating more expeditious diagnostic resolution following
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cancer screening with navigation, Bensink et al reported an increased cost of $275 per
patient with patient navigation compared with control. The overall value and cost savings
in patient navigation is likely understated as this study did note patient navigation
contributed to significantly higher diagnostic resolution and probability of ever having
diagnostic resolution.66
There are limitations of this review as well as the articles included in the review. In
spite of thorough search criteria, it is possible that relevant articles were excluded from
this review. Publication bias is also a limitation as equivocal findings in intervention studies
may not be reported or published. Outcome reporting bias is also a limitation of this
review but using a protocol such that our hypothesis and methods were determined a
priori to the knowledge of the results reduced this. Potential biases were reduced in our
interpretation of the data by employing a systematic approach to our search strategy
outlined above. Conclusions drawn from this systematic review are limited given that a
meta-analysis could not be performed.
Patient navigation is useful in assisting in care delivery for the underserved. This
review supports the use of navigation as an effective tool in increasing adherence to care
in these populations. While certain populations may benefit more from navigation, it has
been shown to work in diverse groups. In the future, it may be beneficial to investigate
different delivery methods for patient navigation, the timing of intervention, and factors
associated with successful patient navigators (i.e. the training and background of patient
navigators). Further research into the use of navigation in the medically underserved will
give more insight into potential uses.

15

CHAPTER TWO: PROMOTION OF EARLY PEDIATRIC HEARING DETECTION
THROUGH PATIENT NAVIGATION: A RANDOMIZED CONTROLLED CLINICAL
TRIAL
2.1 ABSTRACT
2.1.1 Objectives/Hypothesis
Congenital hearing loss is the most common neonatal sensory disorder and it is
crucial to diagnose hearing loss as soon as possible after birth in order to facilitate rapid
treatment. Universal standards of infant hearing healthcare dictate that infant hearing
screening should be completed by one month of age and abnormal screening tests
should be followed with definitive audiological testing by three months of age. Obtaining
diagnostic testing can be complicated by breakdowns in communication, lack of parental
support, and poor coordination of care. There is no established method to effectively
educate parents, promote sound decision-making, and assist in coordinating care
following failed newborn hearing screening testing. Patient navigation, which uses
trained healthcare workers to educate patients and facilitate adherence to healthcare, is
an evidence-based approach that has had widespread success in facilitating timely care
in other healthcare settings but has not been studied in infant hearing testing. The
objective of this research was to decrease non-adherence (lost to follow-up rates) to
recommended infant audiological testing after failed newborn hearing screening. We
aimed to assess the efficacy of a patient navigator intervention to achieve this objective
and we hypothesized that the utilization of a patient navigator would decrease nonadherence to obtain audiological testing following failed screening, compared to those
receiving the standard of care.
2.1.2 Study Design
The study design was a randomized controlled clinical study. Guardian-infant
dyads, in which the infants had abnormal newborn hearing screening, were recruited
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within the first week after birth. All participants were referred for definitive audiological
diagnostic testing at either a University-based audiology practice or a state-funded
audiology clinic. Dyads were randomized into a patient navigator study arm or standard
of care arm. The primary outcome was the percentage of patients with follow-up nonadherence to obtain diagnostic testing.

The participant follow up adherence was

monitored for 6 months after enrollment and the non-adherence rates and timing of
diagnostic testing were compared between groups. Secondary outcomes were parental
knowledge of infant hearing testing recommendations and barriers in obtaining follow-up
testing, which were obtained at enrollment and at the conclusion of the study through
entrance and exit questionnaires.
2.1.3 Results
Sixty-one dyads were enrolled in the study (patient navigator arm=27, standard
of care arm=34). PN was found to be efficacious, as the percentage of participants nonadherent to diagnostic follow-up during the first 6 months after birth was significantly
lower in the patient navigator arm compared with the standard of care arm (7.4% versus
38.2%) based on chi-squared test analysis (p=0.005). The timing of initial follow-up was
significantly lower in the navigator arm compared with the standard of care arm (67.9
days after birth versus 105.9 days, p=0.010). Patient navigation increased baseline
knowledge regarding infant hearing loss diagnosis recommendations compared with the
standard of care (p=0.004). High satisfaction was reported with the patient navigation
intervention.
2.1.5 Conclusions
Patient navigation decreases non-adherence rates following abnormal infant
hearing screening and improves knowledge of follow-up recommendations. This
intervention has the potential to improve the timeliness of delivery of infant hearing
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healthcare and future research is needed to assess the cost and feasibility of larger
scale implementation.
2.2 MATERIALS AND METHODS
2.2.1 Regulatory and Registration Data
Institutional review board approval of the protocol was obtained prior to initiating
the study (protocol 12-1059-P1H). The protocol was registered with ClinicalTrials.gov
prior to initiating the study (NCT01917747).
2.2.2 Participants
We carried out a prospective randomized trial involving a parent or guardian and
their infant who failed infant hearing screening and were referred for outpatient
audiological evaluation. Within this population, the majority of primary caregivers are
mothers and were, thus, the primary candidates for recruitment into this study. The
parent and their child (the dyad) who were referred for testing were eligible for
participation in this study if they met enrollment criteria including being a: 1) Parent with
an infant less than 2 weeks old and born after 34 weeks gestation, 2) Parent whose
infant failed hearing screening (either automated auditory brainstem response test or
otoacoustic emission test) in one or both ears in the newborn nursery, 3) Parents with a
working phone willing to be contacted over the phone by a patient navigator during the
first year after birth. Exclusion criteria include: 1) Parents whose infant was hospitalized
more than 2 weeks after birth, 2) Parents whose infant was born prior to 34 weeks
gestation, 3) Parents of an infant in neonatal intensive care unit, 4) Infants with
outpatient audiological follow-up less than 2 weeks from the time of enrollment, or 5)
Infants who are wards of the state and cases of adoption.
2.2.3 Sample Size Calculation and Recruitment
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The national non-adherence rate following failed infant hearing screening is 25%1
and we proposed that the navigator intervention would decrease the non-adherence rate
to 12%. A power analysis was performed and in order to have 80% power to detect this
difference (at the 0.05 significance level) a sample size of 60 patients was selected. All
potential participant dyads were referred for outpatient definitive audiological testing prior
to discharge from the birthing hospital. Potential participants were identified and
recruited from 3 primary areas: the newborn nursery of a tertiary University-based
medical center (children born within the University system and referred to the University
audiology practice), the same University-based audiology practice (children born outside
of the University but referred to the University audiology practice), and a state-funded
audiology clinic (for children born outside and referred outside the University system).
The recruitment team contacted these areas on a daily basis and verified eligibility.
Potential participants within the University were contacted in person prior to discharge
and those outside the University were contacted by phone within 2 weeks after hospital
discharge. The study was discussed with participants and informed consent was
obtained.
2.2.4 Randomization and Study Protocol
All eligible and enrolled participants were given follow-up appointment dates and
time prior to enrollment, typically one month after birth but no later than 3 months after
birth. In describing the study to eligible candidates, the parent or guardian was told that
their child had referred on a newborn hearing screening for further hearing testing. All
participants were told that they would be obtaining an outpatient appointment with the
ability to contact the referral clinic at any time with questions or concerns. Participants
were told that those agreeing to be involved in the study would be randomized into either
a group that will proceed with their appointment as scheduled without further contact
from the research staff or they would be placed in a group that would be contacted by a
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patient navigator before their appointment. At the time of enrollment and informed
consent, participants completed a previously tested 26-item entrance questionnaire17
(APPENDIX 1) assessing knowledge of infant hearing testing recommendations and
barriers in obtaining follow-up testing. Similar questions regarding knowledge and
barriers were asked at the end of the study for all participants in a 24-item exit
questionnaire17 (APPENDIX 2). These questionnaires have been used previously to
assess parental knowledge, attitudes, and behaviors regarding the EHDI system and
audiological assessment. Following enrollment, the participant dyad was assigned a
study number and was randomized (using block randomization with varying block sizes
to assign participants into either the navigator or standard of care arms). Blocked
randomization of individuals with variable block sizes (differing numbers of participants
per block) ensured equal probabilities of group assignment. A biostatistician created the
computer-generated randomization scheme.
2.2.5 Patient Navigation Intervention
Patient navigation was selected as the intervention for this study because it is widely
effective in other complex healthcare fields, it is extremely useful and appropriate among
rural and low socioeconomic populations, and there is a lack of evidence to support
other methods of improving EHDI non-adherence. The Chronic Care Model39 has guided
the development and implementation of many patient navigator interventions and this
program incorporates key components of this model (FIGURE 2.1). Based on this
model, navigators have the potential to assist patient in the identification and recruitment
of community resources along with health system resources to facilitate delivery of care.
The patient navigator program (PNP) focused on elimination of breakdowns in
communication, parent decisional support, and coordination of care through the complex
EHDI system. An interview guide using semi-structured and open-ended questions was
developed for this study and was piloted tested with parents of children who have gone
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Figure 2.1: Chronic Care Model Constructs for Patient Navigation73
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through the EHDI diagnostic process (APPENDIX 3). Participants randomized to the
PNP group were assigned to a navigator who contacted the participant by phone within
5 days following the assignment with expected interview duration between 10-30
minutes. Through the initial interview, the navigator used the interview guide to assess
the participants’ fears and concerns regarding infant hearing testing, barriers to
appointment adherence, and potential connections to community and healthcare system
support services. Additionally, during the initial interview, the navigator discussed the 13-6 EDHI hearing testing and treatment guidelines. Participants were contacted by
phone weekly (text and email were also offered as alternative communication methods)
after the initial interview to address key discussion points: 1) the status of the
newborn/family and whether newborn hearing testing had occurred, 2) family fears and
reservations regarding the infant’s hearing, and 3) the parent’s knowledge of the
recommended testing/treatment

and the timing

of

appointments

as

well

as

perceived/real barriers to obtaining testing/treatment. During the follow-up interviews, the
navigator provided education on the standard recommendations of infant hearing
diagnostic testing/treatment and the importance of timely adherence to recommended
testing/treatment. The timing of the appointment and the directions to the testing center
were discussed. The weekly phone sessions occurred during the first six months after
the birth of the child concluding when the diagnostic testing was performed. Participants
were given the opportunity to contact the navigator outside of scheduled interviews
based on their needs, concerns, and questions.
Navigators identified specific barriers to care and then assisted participants by
taking actions tailored to the specific needs of the individual. Social support was
provided by supportive listening, providing educational materials, and assisting with
referrals for psychological assistance, if needed. Navigators provided instrumental
assistance by helping participants with making appointments, resolving child-care
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problems, and helping with transportation issues. At the participant level, navigators
educated participants on the 1-3-6 EDHI recommendations for hearing evaluation and
treatment and counseled them on the importance of adherence to follow-up
appointments.
Navigators were selected and trained in accordance with a widely accepted
model established by the National Cancer Institute Patient Navigator Research Program
and the American Cancer Society Patient Navigation Program.74 Patient navigators for
this study included a parent of a child with hearing loss and an adult layperson with
hearing loss. A bilingual (Spanish-English) navigator was also utilized in this study. The
navigators were paid hourly by the primary university conducting the study and they
completed onsite training using multiple modalities that included traditional lectures,
interactive formats, and role-play with case scenarios. They were trained in the
complexity of the EHDI hearing healthcare system and in helping patients navigate
through the process in a timely manner. The navigator’s training involved: 1) rural
context training, 2) EHDI system and audiological testing training with university
audiologists and state EHDI coordinators, 3) medical training with an otolaryngologist, 4)
medical center patient services training with clinical support staff to equip the navigator
with education regarding logistical problems with obtaining appointments, and 5)
navigator telephone training. Following the American Cancer Society patient navigator
model, the navigators contacted participants by telephone.74 Adherence to outpatient
testing was monitored on a weekly basis. Additional appointment variables were also
recorded (number of scheduled appointments, number of attended appointments,
number of rescheduled or “no-show” visits). At the conclusion of the study, participants
completed the Patient Satisfaction with Navigation questionnaire to assess patient
satisfaction with the intervention.75
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2.2.6 Control Group (Standard of Care)
According to EHDI standards, all parents of children who fail infant hearing
screening are given printed educational materials and may view an educational video
regarding infant hearing loss and EHDI services while in the hospital. All participants of
the standard of care group were given their outpatient follow-up appointment prior to
discharge. Once the participant was discharged from the hospital and/or enrolled in the
study he or she did not have any further contact with the research staff. The parent
participant had access to discuss any questions or concerns with the office or audiology
staff, as is the standard of care practice, but this was parent-initiated contact. There was
an automated appointment reminder phone call (which is a medical center standard of
care) that occurred 48 hours prior to the appointment, which requested confirmation of
the planned adherence to the clinical appointment. The research staff monitored
adherence to follow-up of study participants.
2.2.7 Measures
The primary outcome was a dichotomous variable based on whether the child
received the outpatient audiological testing during the first six months after birth.
Adherence was recorded when the participant presented for the audiological testing in
the audiology clinic. Adherence and timing of follow-up was confirmed by crossreferencing with the EHDI state data registry. We also recorded process variables of the
navigator intervention including number of telephone sessions, number of missed or
terminated navigator sessions, reasons for missed sessions, length of the sessions, and
Patient Satisfaction with Navigation questionnaire scores (APPENDIX 4).75 The
secondary outcome of interest assessed was the time interval from birth to the attended
initial outpatient ABR appointment during the first 6 months after birth. The time interval
from birth to final diagnosis was also recorded. Number of no-show office visits and
rescheduled visits were also recorded. Failure to obtain a follow-up within 6 months after
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birth was considered as follow-up non-adherence (lost to follow-up) and 180 days was
designated for these participants in time analyses.
2.2.8 Analysis
Data were managed using the REDCap data collection system and was exported
into an Excel spreadsheet (Microsoft, Redmond, WA, USA), and statistical analysis was
performed with STATA (StataCorp, College Station, TX, USA). Continuous variables
were summarized with descriptive statistics (n, mean, standard deviation) and
categorical variables were described with counts and percentages. A p-value < 0.05 was
considered statistically significant. The effect of sociodemographic variables on the
primary outcome was assessed with multivariate logistic regression analysis. Differences
of follow-up adherence between patient navigator and the standard of care arms were
assessed with chi square analysis and odds ratios were calculated. Process variables
were analyzed in a similar way. Regression analyses (Cox proportional hazard) were
used to detect differences among navigator group and the standard of care group for the
time of diagnostic testing. We used a log-rank test to examine differences in the
distributions of time to first ABR for each group. Corresponding Kaplan-Meier curves
were used to visualize these distributional differences. Comparison of entrance and exit
paired data for the study arms was performed with McNemar’s test as well as the
Generalized Estimating Equation procedure. The data regarding participant knowledge
of hearing loss involved descriptive statistics (means, standard deviations, frequencies,
and ranges) and correlational quantitative methods to compare differences between
study arms.

2.3 RESULTS
A total of 260 dyads were assessed for eligibility between 2014-2016. The
Consolidated Standards of Reporting Trials (CONSORT) flow diagram76 demonstrates
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the subject recruitment enrollment, allocation, follow-up, and analysis (FIGURE 2.2). Of
those assessed for eligibility, 197 were unable to enrolled and consented for study
participation (41 not meeting inclusion criteria, 68 declined to participate, and 88 could
not be reached by telephone). A total of 63 dyads were enrolled and two participant
dyads withdrew from the study. A total of 61 dyads were included in the final analysis
(patient navigator arm = 27 and standard of care arm = 34). The majority of infants were
born in the University medical center and referred to the University audiology practice
(n=34) with smaller numbers born outside the University system and referred to the
University audiology practice (n=15) or born outside the University system and referred
to a state-funded audiology practice (n=12). The demographic information of parental
participants is presented in TABLE 2.1. There was a difference in the educational and
insurance status between the two study arms; however, subgroup analysis within these
areas revealed no significant difference. There was no significant differences in race,
age, socioeconomic status, or other demographic factors between the patient navigator
arm and the standard of care arm. Approximately 28% of the participants reside in rural
counties and the travel distance to the hearing diagnostic center was significantly greater
for those participants than those living in urban/suburban counties (61.8 minutes versus
20.4 minutes, p> 0.001).
During the first 6 months following birth, adherence to audiological follow-up was
monitored in all 61 participants and cross-referenced with the EHDI state data registry. A
significantly lower percentage of participants in the patient navigation arm were nonadherent to follow up compared to the standard of care arm (7.4% versus 38.2%,
p=0.005) (FIGURE 2.3); thereby, confirming the hypothesis of this study. According to
the state registry, those that were non-adherent to follow up in this study did not receive
any audiological diagnostic care at any facility within the state. Of those from rural
counties (n=17), none of navigated participants were non-adherent to follow up while
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FIGURE 2.2: The CONSORT (CONsolidated Standards of Reporting Trials) flow diagram for this study
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TABLE 2.1 Patient Navigator RCT Study Parental Participant Demographical Data
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FIGURE 2.3. Non-adherence to audiological diagnostic testing
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44% of those in the standard of care arm were non-adherent to follow up (p=0.03)
(FIGURE 2.3). The timing of the diagnostic appointment was 67.9 days (range 10 – 180
days) after birth for the navigated participants versus 105.9 days (range 29 - 234 days)
after birth for the standard of care participants. The distribution of this time interval
differed significantly between study arms (p=0.01) (FIGURE 2.4). According to the state
EHDI registry, one participant in the navigation arm was non-adherent with the
University audiology practice follow-up, but had follow-up at another audiology practice
outside of the study sites 10 days after birth. We assessed the effect of variables on
non-adherence, which included rural residence, distance to diagnostic center, number of
children in family, race, language, caregiver age, caregiver educational level, household
income, marital status, child insurance type, family history of hearing loss,
tobacco/alcohol/illicit drug use during pregnancy. Univariate analysis revealed that
marital status was the only variable affecting non-adherence with 41% of unmarried
caregivers non-adherent to follow-up compared with 14% of married caregivers (p=0.02).
Multivariate logistic regression analysis was then conducted based on this finding and
when controlling for maternal marital status, participants receiving the patient navigation
intervention had 83% lower odds of non-adherence than standard of care participants
(p=0.04).
During the diagnostic evaluation multiple appointments may be required for a
variety of reasons (i.e. – rescheduling, failure to follow-up, failure of child to sleep
through ABR testing, middle ear fluid present) and appointment variables were assessed
(TABLE 2.2). Navigated participants had a higher average number of attended
appointments compared with the standard of care participants (p=0.01). Diagnostic
testing was completed within 3 months in 52% of the entire sample (56% in the
navigation arm and 48% in the standard of care arm, p=0.57). The timing of a final
diagnosis

was

96.8

days

(range

10-236
30

days)

after

birth

for

the

FIGURE 2.4. Kaplan-Meier analysis of time (days after birth) to outpatient
audiological diagnostic testing following failed newborn hearing screening
(p=0.010).
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TABLE 2.2. Appointment variables of study participants
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navigated participants versus 114.7 days (range 29-234 days) after birth for the standard
of care participants. Four children in the study were diagnosed with congenital hearing
loss (2 from the navigation arm and 2 from the standard of care arm). These children
sought care outside the primary institution following diagnosis and no further outcome
data is available.
The entrance and exit questionnaire data was available for 43 participants and
revealed their experiences with the infant hearing assessment process as well as their
knowledge of recommendations and perception of barriers regarding infant hearing
healthcare. Approximately 16% of parents did not understand why their child had a
hearing-screening test in the hospital; however, at the entrance of the study, 98% of
participants agreed that obtaining follow-up for their child’s hearing was important.
Regarding outpatient testing, 66% of participants reported that they did not know what to
expect and 52% reported that they were not knowledgeable regarding the testing
process. In assessing knowledge of infant hearing loss and treatment, 33% did not know
the recommended time for infant hearing diagnosis (within 3 months of birth). The
participants in the patient navigation arm increased in their knowledge of the
recommendations on outpatient audiological follow up during the course of the study
(54% correct on entrance versus 78% correct on exit) compared with those in the
standard of care arm (76% correct on entrance versus 52% correct on exit) (p=0.004)
(FIGURE 2.5). Overall, the participants reported a high level of confidence with obtaining
follow-up (97%) at the beginning of the study, which was also reflected on the exit
questionnaire (100%). At the conclusion of the study, 74% reported that they would be
comfortable talking about their child’s hearing with others and 98% were willing to
provide information regarding the hearing testing process to other parents. Multiple
barriers to obtain follow-up testing were assessed in the entrance and exit
questionnaires (FIGURE 2.6).
33

FIGURE 2.5. Assessment of participant knowledge of EHDI recommendations regarding timing of audiological diagnostic
testing and treatment of hearing loss (diagnosis by 3 months and treatment by 6 months of age) at the time of study
enrollment and exit.
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FIGURE 2.6. Assessment of participant barriers to obtain hearing assessment at the time of study enrollment and
exit.
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Data from the patient navigation intervention were analyzed in 25 of the 27
participants receiving the intervention and results were compared between rural
residents and urban residents (TABLE 2.3). Data regarding navigation variables was
incomplete with 2 participants and this was not included in the analysis. The navigator
contact

with

participants

occurred primarily

over

telephone calls,

but

some

communication occurred through mobile phone texting. Contact with patient navigation
participants was complicated by inactive mobile phone service (monthly minutes cellular
phone plans) or disconnected numbers. Patient navigation satisfaction was also
assessed at the conclusion of the study and the intervention was rated highly (TABLE
2.4).
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TABLE 2.3. Patient navigation intervention variables

37

TABLE 2.4. Patient navigation satisfaction data
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2.4 DISCUSSION
Pediatric hearing loss constitutes a major public health problem and delayed diagnosis
can lead to life-long communication deficits. Early identification and treatment of infant
hearing loss is essential but unfortunately delayed in many children.13-15 This research
addresses a significant gap in the field of early hearing diagnosis and intervention
research. There is no literature that addresses the efficacy of initiatives designed to
decrease non-adherence in follow-up after infant screening for diagnosis or hearing loss
intervention. Contact with parents after infant hearing screening may influence followup.31 Parent-to-parent programs, such as Guide By Your Side,32 are available in many
states and may reduce parental isolation and boost parental acceptance of the child’s
condition.22 Current programs typically require the parents to make initial contact to
establish services and often are not utilized until a diagnosis of hearing loss is made. No
previous studies have examined the use of a patient navigator following infant hearing
screening; however, navigation is an intervention model that is well suited to address
non-adherence. The original concept and development of this intervention stems from
the findings of the American Cancer Society National Hearings on Cancer in the Poor in
1989 and the subsequent work of Dr. Harold Freeman to develop the first patient
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navigation program to promote timely cancer treatment in the inner city of New York.

Since that pilot program, many cancer centers have been using patient navigators to
improve the quality and timeliness of care This study demonstrated a decrease in the
lost to follow-up rates in participants that received the patient navigation intervention
after discharge from the hospital compared with the standard of care arm of the study. In
spite of a small sample of rural participants, the intervention was similarly efficacious in
rural residents. Randomization in study arm allocation helps to strengthen the validity of
the findings.
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Many efforts are underway in EHDI programs nationwide to improve infant
hearing testing. Screening tests such as automated ABR and OAE have many falsepositive results that lead to medical staff and parents dismiss and devalue the screening
results and the importance of definitive adherence of infant.17 Double screening while in
the newborn nursery is currently being investigated to decrease the false positive rate.
Further efforts to improve adherence include hospital scheduling of outpatient testing
and more effective communication with primary care physicians. Better communication
between EHDI programs and primary care physicians may also improve adherence rate.
This will provide additional opportunities to educate providers on the importance of
timely infant hearing assessment. Many factors and barriers complicate timely access to
healthcare. Misinformation, inconsistent care, cultural or health beliefs, socioeconomic
status, mistrust of the healthcare system, and lack of social support influence nonadherence within healthcare.51 Within the EHDI field, factors complicating access to care
include poor communication of hearing screening results, difficulty in obtaining outpatient
testing, inconsistencies in healthcare information from primary care providers, lack of
local resources, insurance-related healthcare delays, and conflict with family and work
responsibilities.77 Addressing these barriers to care is complicated and may require
multiple approaches. Families of children with hearing loss report that they lack
confidence and resources needed for healthcare decision-making for their child.22
Parents of children with hearing loss also lack role models who have been through the
complex process of hearing loss diagnosis and intervention.22 In previous research,
prenatal educational modules29 and social worker counseling30 have not demonstrated
significant benefit in promoting rescreening after a failed infant hearing screening. The
personalized patient support and continuity of education and assistance may
differentiate patient navigation from other care coordination models. This method of
educating patients through patient navigation may be a potential mechanism for
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improved adherence with testing in this population, as there was evidence in this study
of an improved knowledge base in navigated participants regarding EHDI hearing
assessment and treatment recommendations. Navigation also has the potential to
address multiple personal and external barriers that prevent adherence and access to
care. A small percentage of the participants in this study reported on barriers to obtain
infant hearing assessment; however, there was a trend toward a decrease in insurance
barriers and home responsibilities barriers in the navigated patients at the conclusion of
the study. A sampling bias is present in barrier assessment in this study as there is a
lack of data from those that were lost to follow up and the responses of those
participants would likely be informative. Further research is needed to capture data
regarding barriers on those lost to follow up which may employ participant interviews to
identify barriers to care.
Patient navigation has been successfully implemented within the oncology field
to improve access to care in underserved populations and overcoming barriers to their
care. A variety of types of navigators has been reported and may include lay people
who have had personal experience with the disease and represent the population they
were serving.62 Others have reported using professional health care workers66 or social
workers64 to perform navigation activities. Bilingual navigators may further improve
adherence with non-English speakers.68 The structure of a navigation intervention may
involve a highly structured guide or assessment tool or an informal discussion of barriers
to care.59,64-67 Within the field of oncology, navigators have assisted patients in
overcoming obstacles such as lack of transportation, lack of insurance, poor
coordination of healthcare appointments, language barriers, and limited healthcare
literacy.59,64,67 The timing of navigation is also associated with the success of such a
program67 as navigation is more effective if it is initiated shortly after an abnormal
screening test and may increase adherence with obtaining definitive diagnostic testing.
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The implementation and sustainability of patient navigation within infant hearing
healthcare is dependent on cost. There is a lack of cost assessment of patient
navigation within established oncology navigation programs; however, one such
program reported an increase in cost of $275 per patient with patient navigation
compared with the control group during the course of screening testing leading to
diagnostic testing.66 The cost of a patient navigation program within EHDI programs is
unknown and deserves further study. Method of intervention delivery also deserves
further attention, as it may be possible to deliver patient navigation through remote
access or telehealth link. Telemedicine may also allow connection of patients to
providers; however, consistent delivery of infant hearing diagnostic testing can be
complicated by cost and fidelity of testing. Telemedicine may also be a means to
education caregivers and audiologists in remote areas to improve efficiency and
accuracy of infant diagnostic hearing testing. Further research is needed on cost
assessment and cost effectiveness of telemedicine interventions and other interventions
developed to expand access to care.
This study was complicated by difficulty in recruiting all eligible study participants.
When evaluating potential participation into the study, 68 parents did not wish to
participate, primarily due to concerns with randomization in study arm allocation. Most of
these parents expressed concern and did not wish to be randomized into the control
group as they wished to receive every possible resource to aid in their child’s hearing
testing follow-up. Others expressed concern over being enrolled in a research study, as
they perceived they might receive substandard care. In spite of careful explanation of the
study, these 68 did not wish to participate. A concerning number of participants (N=88)
were potentially eligible for the study; however, they could not be contacted by phone.
Most of these potential participants had provided mobile cell numbers; however, when
research staff attempted to contact these individuals their phone usage minutes had
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been maximized or the number was no longer in service. Most participants did not
provide alternative numbers; therefore, we were unable to contact them. Some of these
patients may have been discharged from the primary University recruitment site during
evenings or weekends and were not visited by study staff while in the hospital.
Adjustments were made to recruiting methods to prevent the loss of these participants.
Most of the 88 parents were referred to a facility outside the main university and there
was no direct contact between that clinic, the university, or the research staff. This group
of parents is an important subset of patients that need further research and attention.
Parents that leave a small birthing hospital and are not given follow-up appointments
and cannot be contacted by phone are at a significant risk for non-adherence. Additional
uncontrolled variables and design limitations to this study may limit the generalizability of
the findings. Since these participants were never contacted, informed consent was not
obtained and we are unable to investigate the status of follow-up or outcomes of this
group. It may be possible to increase recruitment among participants such as these by
sending study information documents to the home address of these participants. By
partnering with state EHDI system, it may be also possible to increase recruitment by
sending study information to the primary care physician caring for that newborn.
Connecting with the parents who were not enrolled initially into the study could provide
valuable information regarding knowledge, attitudes, and behaviors regarding infant
hearing testing adherence. Increased efforts to contact the parents prior to discharge
may also bear fruit.
Attention bias is a potential limitation of this study as the intervention group may
have had improved adherence to follow-up due to increased contact alone while the
standard of care group had less contact and thus had poorer adherence. While this was
not directly controlled for in this efficacy study, other studies that have had increased
contact with parents through prenatal educational modules32 and social worker
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counseling30 has not demonstrated significant benefit in promoting rescreening after a
failed infant hearing screening when compared with control groups. The mechanism
behind the efficacy of navigation delivery is unknown and further research, through
mixed quantitative and qualitative methods, is needed. Another potential limitation
includes selection bias with differences in the demographics of the study samples.
These differences could influence the results (i.e. overall educational level and insurance
status); however, subgroup analyses within these areas reveal no significant differences
and household income is similar between the two study arms. An additional factor that
could influence the outcomes of this study involves the type of education and level of
communication

provided

in

different

birthing

hospitals

(prior

to

enrollment).

Randomization in the study design may decrease the influence of this factor; however,
there remains significant variability in the teaching provided directly by healthcare staff
(or lack thereof), as well as, the educational resources provided to parents of infants who
fail newborn screening. An additional limitation includes a lack of long-term follow up and
assessment of the effect of patient navigation on timing of treatment for those diagnosed
with hearing loss in this study. Finally, this study was limited in that a single parent or
caregiver was targeted for the intervention; however, other caregivers (grandparents or
other family members) may be vital targets for navigation and further research is needed
to assess the role of other care providers in adherence to outpatient diagnostic testing.
Patient navigation is a promising intervention to promote adherence to infant
hearing assessment following failed screening. Further work is needed in this field to
assess, through multivariate analysis, key factors that influence non-adherence with
testing. By identification of the key factors in non-adherence, navigation may be modified
and customized to target those factors to maximize appointment adherence. The method
of navigation intervention delivery is an area for future research as well. The lack of
consistent phone service in lower socioeconomic groups is a significant barrier to
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communication in healthcare, which also complicated patient navigation in this study. Inperson delivery of navigation could help address this communication gap. Home visits
with participants would be a potential method to increase the strength of the patientnavigator relationship. Development and implementation of a community-based
navigation program that will monitor long-term hearing outcomes may have greater
reach into remote areas to educate and support these patients. Further research is
needed to investigate the effectiveness of patient navigation on a larger statewide level
and investigate that implementation factors that enable patients to successfully
navigation the hearing healthcare system. Additionally, assessment of the cost of patient
navigation may influence the likelihood of integrating it into state EHDI programs.
Performing cost-benefit analysis of patient navigation in the future will require long-term
assessment of speech and language outcomes along with costs associated with
rehabilitation and education of children with hearing loss.
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CHAPTER THREE: HELPING INFANTS GET HEARING RESOURCES: THE HIGHER
PATIENT NAVIGATOR TRIAL

3.1 SPECIFIC AIMS
As the most common neonatal sensory disorder, infant hearing loss has an
incidence of at least 1.6 per 1000 births.1 Early childhood hearing loss that is not
identified and treated appropriately usually results in significant delays in language,
cognitive, and social development,2 with profound later effects on education and
employment.3 The economic costs of hearing loss are substantial; the overall lifetime
medical, educational, and occupational costs due to deafness are estimated to be $2.1
billion.4 The U.S. Preventive Services Task Force (USPSTF) reported that early
detection and intervention of infant hearing loss decreases speech impairment,
social/emotional challenges, and learning/behavioral disorders.5-7 The Joint Committee
on Infant Hearing (JCIH) recommends that all infants be screened before 1 month of
age, diagnosed before 3 months of age, and initiate treatment before 6 months of age
(often referred to as the “1-3-6 rule”).12
Early infant hearing detection and intervention (EHDI) programs are coordinated on
a state level; however, non-adherence to diagnostic testing after failed newborn
screening is a national problem. EHDI programs aim to have 90% of U.S. infants with
failed infant hearing screens tested and diagnosed within 3 months of failed screening,
but fall unacceptably short: only 41.1% meet that standard.1 Heightening the concern for
life-long complications due to delayed diagnosis following a failed newborn screening,
the outpatient diagnostic and hearing loss treatment process is complex and difficult for
parents to navigate.16 Families of children with hearing loss are often uninformed
regarding the EHDI process and lack peer support in obtaining care for their child.21,22
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Similar problems in cancer care have been addressed with patient navigation (PN)
programs, leading to improved adherence to recommended diagnostic testing after
abnormal screening and resulting in improved patient care and healthcare system cost
savings.45,50,64 Patient navigators (PNs) are trained healthcare workers who assess and
mitigate personal and environmental barriers to promote healthcare adherence and
improve access to care.34
We have recently conducted a randomized controlled efficacy trial of PN in
collaboration with the Kentucky EHDI program and have demonstrated significantly
decreased infant hearing diagnostic testing non-adherence (7%) compared to the
standard of care (38%)(p=0.005). However, PN has yet to be tested or systematically
implemented within state EHDI programs. Further, there is a major gap in the hearing
healthcare field regarding effectiveness and implementation research on interventions
designed to decrease infant hearing diagnostic non-adherence.33 To address this
significant gap in research and practice, an effectiveness trial of PN coupled with
implementation research would inform its potential scale-up to maximize public
health impact. The proposed research is a type 2 hybrid effectiveness-implementation
trial78 of a PN intervention aimed at decreasing infant hearing diagnosis non-adherence
after failed newborn hearing screening, delivered in 10 state-funded EHDI program
clinics. This design allows for simultaneous assessment of the effectiveness of a clinical
intervention, while comparing implementation methods. Using a stepped wedge design,
we will:

Specific Aim 1: Test the overall effectiveness of PN to decrease non-adherence to
receipt of infant hearing diagnosis within 3 months after birth. Hypothesis: PN will
decrease non-adherence to obtaining infant hearing diagnosis within 3 months after birth
compared to the standard of care. In Aim 1, effectiveness of PN to decrease clinic-level
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non-adherence rates will be tested via comparison to non-adherence rates during the
standard of care condition.

Specific

Aim

2:

Explore

associations

among

implementation

factors,

implementation outcomes,79 and effectiveness outcomes. Research questions: (a)
What are the associations of inner clinic setting characteristics (I.e. - clinic resources,
clinics’ need for change, clinic culture, clinic readiness for implementation), outer clinic
setting characteristics (patient needs and resources, external policy and incentives), and
PN

characteristics

with

adoption,

recruitment/retention,

reach/penetration,

and

sustainability? (b) How does PN modality—local or centralized—affect clinic-level nonadherence rates? Aim 2 will employ mixed methods to provide valuable information
regarding key factors associated with implementation and effectiveness outcomes.

Specific Aim 3: Determine the cost-effectiveness of PN from the perspective of
third party payers. Hypotheses: (a) PN via either local or centralized delivery will be
cost-effective compared to the standard of care from the perspective of third-party
payers; (b) Centralized PN will be as or more cost-effective as local PN. In Aim 3, net
costs and net effectiveness of PN will be compared with standard of care.

This study is significant because it aims to reduce non-adherence to timely infant
diagnostic hearing testing to prevent life-long negative consequences. It harnesses our
research team’s existing collaborations and expertise in addressing hearing healthcare
disparities with culturally appropriate interventions. This research is innovative in testing
an intervention not previously assessed in hearing healthcare within a state-funded
EHDI program, and in integrating implementation research and cost-effectiveness
methods with our effectiveness aim. Our results will impact the field by informing
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potential scale-up of this and other innovative patient supportive interventions to create
efficient and effective EHDI programs and maximize public health impact.

3.2. SIGNIFICANCE
3.2.1: The Importance of Assessing PN Effectiveness and Implementation Factors
For PN to be scaled up to maximize public health impact, effectiveness trials
must be coupled with implementation research. A key challenge in implementing any
evidence-based program is understanding and addressing the multilevel factors
influencing the success (or lack thereof) of whether and how an intervention is delivered.
There is no research or clinical standard in hearing healthcare to guide the development,
scope, or delivery of programs to reduce non-adherence. However, state-funded EHDI
programs provide infrastructure within each state to assess and track hearing in young
children, providing an ideal platform for the delivery of PN targeting infant hearing testing
and treatment. EHDI programs have the capacity to target the most vulnerable patient
populations (e.g., low levels of parental education, low socioeconomic status, public
insurance), who are also at highest risk for non-adherence with recommended
diagnostic testing.15,17-20 In Kentucky, audiology clinics serving EHDI patients are
administered by the Kentucky Commission for Children with Special Health Care Needs
(CCSHCN). By partnering with EHDI and CCSHCN to conduct this research, we can
assess not only effectiveness of PN, but also implementation factors, outcomes, and
costs expended/averted in the settings intended to reach the most vulnerable patient
populations in our state.
3.2.2: The Project Goal
The overarching goal of the proposed research is to conduct a type 2
hybrid effectiveness-implementation trial78 of a PN intervention aimed at
decreasing infant hearing diagnosis non-adherence after failed newborn hearing
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screening, delivered in state-funded EHDI clinics. Hybrid designs in implementation
science offer rigorous and efficient approaches to simultaneously assess the
effectiveness and implementation of interventions and programs delivered in community
settings and thus are ideal for the proposed project.78 Type 2 hybrids directly blend
clinical effectiveness and implementation research aims toward more rapid translation to
practice. Effectiveness, implementation outcomes, implementation factors, and costeffectiveness of PN will be assessed.
3.2.2: Summary of Significance
The scientific premise of the proposed study is based on our own and others’
research showing that: 1) delayed diagnosis of pediatric hearing loss has profound lifelong negative effects, yet non-adherence rates for diagnostic testing are unacceptably
high; 2) there is a pressing need for a scale-able evidence-based approach to address
this public health problem; 3) PN is efficacious to reduce non-adherence to infant
hearing diagnostic testing, but lacks effectiveness evidence; and 4) understanding of
implementation factors and cost-effectiveness of PN are critical to potential scale-up of
this intervention. Our findings will directly inform state-level policy and services impacting
children with hearing loss and set the stage for a national multi-site implementation trial
and potential scale-up to maximize public health impact.

3.3 INNOVATION
3.3.1: Investigating PN delivered within state-funded clinics is a novel step forward in
developing efficient, effective, and scale-able EHDI programs.
PN is an ideal intervention model to implement in the field of hearing loss
because it is evidence-based and distinct from existing programs in hearing healthcare
and EHDI settings. As demonstrated in the cancer field, PN can be effectively delivered
and scaled-up to a broader level. EHDI programs do not have an evidenced-based
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standardized program that addresses non-adherence to diagnostic testing in infants; PN
has the potential to fill this gap and could become a national standard in EHDI programs.
3.3.2: An evidence-based preventive intervention targeted to parents/caregivers of
infants immediately after abnormal screening is a novel strategy to improve EHDI
system efficiency.
This intervention differs from other EHDI parent support programs (i.e., Guide by
Your Side) because it is integrated into the referral to the EHDI program and support is
provided before the scheduled diagnostic testing appointment. Other programs (i.e.,
Guide by Your Side and tele-audiology) require families to voluntarily seek support and
typically occur after the diagnosis of hearing loss, which may be delayed. Delivery of PN
shortly after abnormal screening, rather than at the time of follow-up/diagnosis, could
improve the efficiency of EHDI and expedite pediatric hearing loss diagnosis and
treatment.
3.3.3: The utilization of a type 2 hybrid effectiveness-implementation study using a
stepped wedge trial design is innovative in this field.
This study allows for multilevel intervention and analysis of clinical effectiveness
and implementation outcomes at the clinic level and the patient level. Given the positive
results of our preliminary efficacy trial, the pragmatic stepped wedge design is preferred
to a randomized controlled trial design due to ethical and feasibility concerns,80 while still
allowing rigorous design and robust evaluation. This study design is unique in the field of
pediatric hearing loss and would significantly advance the field.
3.3.4: The delivery of preventive interventions to high risk and underserved communities
is often overlooked but is an essential component of this research.
Disparities in underserved populations are a NIDCD priority area.81 However, no
intervention studies have targeted rural pediatric hearing loss and hearing healthcare
disparities. This proposal is responsive to and innovatively addresses the NIDCD
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Strategic Plan Priority Area 4, focused on increasing access to health care and
enhancing delivery of care.81
3.3.5: The cost analysis component of this study will use a novel simulation modeling
approach that accounts for multi-site variation at both the individual patient level and
programmatic level.
This will allow us to provide cost-estimates of PN, and more importantly, provide
evidence about the economic feasibility of implementing PN on a larger scale.

3.4 APPROACH
3.4.1 Overview
We propose a rigorous, type 2 hybrid effectiveness-implementation trial testing a
PN intervention to reduce infant hearing diagnosis non-adherence after failed newborn
hearing screening. Using a stepped wedge trial design, PN will be implemented
sequentially in each of 10 state-funded Kentucky CCSHCN clinics randomized to cross
from usual care to PN in steps of 6-month intervals over the project period (Aim 1). Prior
to initiation of PN at each clinic, the control condition will be the standard of care. The
overall effectiveness of PN will be tested by comparing non-adherence rates during the
PN condition to those during the standard of care condition. We will also assess key
factors associated with implementation outcomes at each clinic (Aim 2), including
potential effects of using centralized versus local PNs. Finally, we will determine the
cost-effectiveness of PN from the perspective of third party payers, using a novel
simulation modeling approach accounting for multi-site variation at both the individual
patient level and programmatic level (Aim 3). Successful completion of our aims will
inform EHDI programming to (1) reduce infant hearing diagnosis non-adherence, (2)
facilitate development of a multi-state implementation trial of PN to further support scaleup, and (3) contribute to the developing field of implementation science. Our highly
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collaborative interdisciplinary research team has collective expertise in hearing
healthcare

disparities,

behavioral

clinical

trials,

community-engaged

research,

implementation science, and health economics/health policy. We are uniquely positioned
to conduct this project with our existing collaborations, the support and engagement of
strong research partnerships with Kentucky’s CCSHCN and its EHDI program, our
network of audiologists and hearing healthcare providers across the state, and
outstanding consultants providing support for each aim.

3.4.2 Pilot Studies
1. The complexities of the EHDI system influence timing and access to care in
largely rural states. This transdisciplinary research team has recently completed a
series of studies documenting:
a. Delayed treatment results from infant hearing testing non-adherence
following newborn hearing screening in rural communities: In a retrospective
review of 2009-2011 state EHDI data, we have found that infant hearing loss occurs
in 1.7 of 1000 live births in Kentucky.13 Of those with failed newborn hearing
screening, 27% of children born in rural regions were non-adherent to obtain
diagnostic testing.13 Children from rural areas were also delayed in intervention.14,15
b. Primary care physicians face barriers to promote EHDI initiatives: In a crosssectional survey of 93 rural physicians, many providers reported that they do not
receive newborn hearing screening results consistently and they lack confidence in
counseling parents through the EHDI process.82
c. Lack of parental knowledge and support to navigate the EHDI system: In
quantitative and qualitative studies investigating parental knowledge, attitudes, and
behaviors regarding the EHDI system, more than 20% of parents found the process
of newborn hearing testing difficult, and many were unaware of the screening
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results and need for follow-up at the time of hospital discharge.17 Misinformation
from providers and difficulty coordinating appointments were prominent barriers to
infant hearing testing.77
Importantly, the state EHDI program is the only entity to follow up on outpatient
testing; thus, successful collaboration with the EHDI program and CCSHCN clinics is
essential. In each of the above studies, close collaboration with our state EHDI
program was crucial. These studies demonstrate the expertise and history of
collaboration among the PI, co-investigators, and the EHDI program and
CCSHCN clinics in investigations of the causes and effects of infant diagnostic
hearing testing non-adherence.
2. PN is Efficacious in Promoting Timely Infant Hearing Healthcare. We have
recently conducted a randomized controlled clinical trial (N = 63) with parents of
infants with abnormal newborn hearing screening. Dyads who were referred for
audiological diagnostic testing were recruited from an academic hospital birthing
center within the first week after birth and randomized to PN or standard of care.
Receipt of diagnostic testing was monitored for 6 months after enrollment and the
non-adherence rates and timing of diagnostic testing were compared between
groups. Significantly fewer participants in the PN arm were non-adherent to follow-up
testing compared to standard of care (7.4% vs 38.2% overall, p=.005; 0% vs 44%
among rural participants, p=.03). Timing of the diagnostic appointment was 67.9 days
(range 10-180 days) after birth for PN participants versus 105.9 days (range 29-234
days) for standard of care (p=0.01). PN participants increased knowledge of
diagnostic testing recommendations (54% correct on entrance versus 78% correct on
exit) compared with those in the standard of care arm (76% correct on entrance
versus 52% correct on exit) (p=0.004). This study was conducted in collaboration
between UK and several CCSHCN clinics, and demonstrates (a) the expertise of
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the investigative team in conducting clinical trials involving PN in this
population; (b) justification for studying effectiveness and implementation of
PN; (c) feasibility of the proposed project; and (d) successful collaboration with
our state and community partners.
3. PN Procedures are Feasible and Acceptable but Require Flexibility. Analyses of
process data from the PN arm revealed that while PN contact with participants
occurred primarily over telephone calls, some communication occurred through
mobile phone texting. Contact was sometimes complicated by inactive mobile phone
service or disconnected numbers, suggesting that facilitating multiple modes of
contact (including in-person) could increase uptake of the program. Patient
satisfaction with PN was also assessed at the conclusion of the study and the
intervention was rated highly by parents. This study demonstrates the expertise of
the investigative team in assessing PN feasibility/acceptability and lays the
groundwork to assess different implementation strategies in this population.

3.4.3. The PN Intervention
PN is widely effective in other complex healthcare fields, as well as accepted and
effective among rural and low socioeconomic status populations. PNs are trained
individuals who assess and mitigate personal, interpersonal, and environmental barriers
to healthcare adherence, consistent with the tenets of SCT24-27 toward promoting healthy
behaviors. Our PNs will work with participants to identify and address specific barriers to
obtaining follow-up diagnostic hearing testing for their infants, provide social support via
supportive listening, provide educational materials, and provide referrals for additional
assistance, if needed.75 PNs will provide instrumental assistance by helping participants
make appointments, resolve child-care problems, and address transportation issues.83
PN selection criteria and training will be in accordance with a widely accepted
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model established by the National Cancer Institute Patient Navigator Research Program
and the American Cancer Society Patient Navigation Program.74 Potential PNs will be
identified from an existing pool of parents/patients who have requested to be involved in
hearing healthcare research and patient advocacy maintained by Kentucky’s CCSHCN
(see C.6.a for details). At least one bilingual (Spanish-English) PN will be recruited for
each site. All PNs will complete a 3-week curriculum involving:
1) Standardized PN Training: PNs will complete the training and fidelity standards set
by a National Patient Navigator training program.74 It is important to establish that
there is currently no subject-specific standard protocol for PN for families in the EHDI
system; thus, our PN efficacy trial guided content development of our training
protocol. The positive results of our efficacy trial support our PN curriculum.
2) Audiology/EHDI System Training: PNs’ audiological training will be directed by Dr.
Shinn, who serves as the co-chair of the Kentucky EHDI advisory committee and has
extensive knowledge of audiological resources across the state. Initial audiological
training will involve three hours of formal lecture covering the process of diagnosing
and treating infants with congenital hearing loss. These will be supplemented by
appropriate and relevant readings (i.e., JCIH 2007 Position Statement12), adjusted to
a sixth grade reading level. Our consultant Dr. White serves as the director of the
National Center for Hearing Assessment and Management (NCHAM) and will provide
further resources for PNs from the NCHAM website (www.infanthearing.org).84
Finally, PNs will participate in 8 hours of experiential training in which they will
observe live patient encounters, testing equipment/procedures, and clinic procedures,
including scheduling.
3) Patient Communication Strategies and Resource Development: Using resources
from a national PN collaborative (http://patientnavigatortraining.org),85 PNs will be
trained in communication strategies, developing community resource maps,
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interviewing skills, conflict resolution, and professional boundaries.

Navigator intervention delivery will follow the American Cancer Society PN model.74
Navigation will be delivered through either local PNs (parents from the same geographic
region as the clinic) or centralized PNs (parents at the PI’s institution; see C.4 and C.6
for details). PNs will seek to identify parent needs, connect parents to community and
social support services, facilitate interaction and communication with healthcare staff
and providers, and provide health education, all toward the goal of obtaining diagnostic
hearing testing for their infant. PNs will contact parents by telephone for an initial
interview, building rapport and assessing needs and resources. PNs will then contact
parents weekly using the parent’s preferred method (phone or text – local and
centralized PNs; in-person visits – local PNs only). Weekly PN contacts will continue
until the diagnostic test has been obtained (verified by EHDI data) or until 12 weeks
since birth have elapsed, whichever occurs first.

3.4.4 Overall Study Design
We propose a rigorous stepped wedge randomized prospective trial to achieve
our 3 aims investigating the (1) effectiveness, (2) implementation, and (3) costeffectiveness of PN versus standard of care in reducing infant hearing diagnosis nonadherence after failed newborn hearing screening.
The state-level EHDI and CCSHCN are our partners in this research, and we
have existing collaborations with audiologists and staff at all of their clinic sites.
CCSHCN has agreed to engage 10 of their 11 clinics in this study. (The number of
infants referred annually to the 11th clinic is <16, making it inappropriate for this study.)
The Kentucky EHDI Advisory Board has also fully supported this study.
The 10 participating clinics represent a cross-section of the Kentucky population
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with urban and rural settings and are located in Knox, Warren, Hardin, Perry, Fayette,
Rowan, McCracken, Floyd, Pulaski and Jefferson counties (FIGURE 3.1). These clinics
provide 500-600 diagnostic hearing tests per year following failed newborn nursery
screening, but not all meet the 1-3-6 rule. An additional ~100 referrals are made to each
clinic each year that do not result in diagnostic testing. Overall, of all referred infants,
25.9% are non-adherent to diagnostic follow-up testing within 3 months of birth.
Under a sequential rollout in steps of 6-month intervals, the 10 clinics will be
randomly

allocated

to

implement

PN

over

the

project

period

(FIGURE

3.2). Randomization will be stratified by clinic patient population size and conducted by
our study biostatistician, Dr. Westgate. The highly pragmatic stepped wedge trial design
will allow all clinics to contribute control group data as well as intervention data. Note
that during the first 6 months of the project, all 10 clinics will be in the control condition.
The first clinic will cross to the intervention condition following month 6 of Y1, and the
10th clinic will do so following month 6 of Y4 of the project period. PN delivery will
continue through the first half of Y5.
Additionally, clinics will be randomly allocated to either local or centralized PN by
Dr. Westgate. Based on our preliminary feasibility and acceptability results (see pilot
study (c) under C.2), combined with our previous work in cultural adaptions and delivery
of parent-focused interventions in rural Appalachian communities,86 local PNs may be
more acceptable to parents than centralized PNs. Including two intervention modality
conditions will allow investigation of this implementation factor in Aim 2.
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FIGURE 3.1 : Number of Unique Infant Hearing Diagnostic Tests per CCSHCN
Clinic
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FIGURE 3.2: Stepped Wedge Trial Design
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3.4.5. Aim 1 Methods: Test the effectiveness of PN to decrease non-adherence
to receipt of infant hearing diagnosis within 3 months after birth compared to
standard of care.
Aim 1 Study Sample and Recruitment
Clinics: The 10 participating clinics are described above under 3.4.4.
Parent-Infant Dyads: Given the referral data described in 3.4.4, we anticipate ~1700
referrals to the 10 clinics during their time in the PN intervention condition (i.e., an
average of 68 referrals per year per clinic, with clinics randomized to receive PN for
periods spanning 1 to 4 years). In our efficacy trial, 84% of all referred dyads were
eligible. Thus, we anticipate ~1400 eligible infant referrals to the clinics while in the PN
condition, and we aim to enroll 80% of all eligible dyads (N=1120 dyads). Inclusion
criteria include: 1) Parents whose infants fail hearing screening in one or both ears
before postnatal hospital discharge, 2) whose infants are referred for follow-up
diagnostic testing at one of the 10 participating CCSHCN clinics, and 3) who are ages 18
and older. Exclusion criteria include: 1) Infants hospitalized past 30 days after birth, 2)
parents who live outside Kentucky or will be moving out of state within the infant’s first 3
months of life, or 3) infants who are wards of the state.
Once a clinic crosses from standard of care to PN in the stepped wedge design,
recruitment of all eligible parent-infant dyads in that clinic will begin. Prior to postnatal
hospital discharge, parents whose infants fail their newborn hearing screening test are
referred to university-based, private, or CCSHCN hearing centers for follow-up testing.
The referral and contact information for these parents is collected and maintained by the
state EHDI program. Within one week of postnatal hospital discharge, research
personnel will contact by phone each parent referred to a clinic in the PN condition to
describe the study, screen the parent-infant dyad for eligibility, and invite eligible dyads
to enroll in the study. Informed consent will be obtained over the phone and will include
permission from parents to access their infant’s hearing data from EHDI.
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Aim 1 Procedures
Clinics: All data collected on non-adherence to follow-up within 3 months after birth will
be at the clinic level. The primary effectiveness outcome is the proportion of nonadherent referrals for diagnostic testing at each clinic during each month of the trial.
Clinic-level data will be compiled on a monthly basis by CCSHCN co-investigator Cathy
Lester. The effectiveness of PN (regardless of local versus centralized) to decrease nonadherence rates will be compared to the standard of care condition.
Parent-Infant Dyads: Within one week of study enrollment, a trained research assistant
will administer by phone baseline measures of knowledge of hearing loss, self-efficacy
for obtaining follow-up testing, and real and perceived barriers in obtaining follow-up
testing. In the event of an non-operational phone, the participant will be mailed the
baseline measurement questionnaire which will be returned in a stamped return
envelope. Following completion of baseline measures, parents will be contacted by the
PN to initiate intervention delivery as described in C.3.b above. Post-test measures will
be administered by phone by a research assistant 16 weeks after birth; the research
assistant will not have access to data regarding parents’ follow-up with diagnostic
testing. Parent participants will be compensated $20 for each set of completed
measures (i.e., at baseline and at post-test assessment).
Measures: Secondary effectiveness outcomes include parent participants’ knowledge,
self-efficacy, and barriers regarding obtaining follow-up diagnostic testing for their infant.
Parent knowledge will be assessed using 4 multiple-choice items on diagnostic testing
purpose and recommendations. These items were developed in our preliminary RCT
and yield knowledge scores from 0-4. Parent self-efficacy to obtain diagnostic testing
for their infant will be measured using a 10-item self-efficacy scale adapted from an
existing measure examining self-efficacy to obtain cancer screening.87 Each item uses a
5-point Likert-type response scale and addresses one step associated with the process
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of obtaining testing (e.g., making an appointment, transportation, payment, proceeding
when worried, and others). Scores range from 10 (low self-efficacy) to 50 (high selfefficacy). Parent-identified barriers will be measured using five items with 5-point
Likert-type response options. The items tap barriers to obtaining diagnostic testing
identified by parents in our preliminary studies,17,77 and scores range from 5 (minimal) to
25 (many). We will obtain EHDI clinic data for all enrolled infants until their one-year
birthday (or until data collection ends) to determine the time from birth to initial
completed outpatient hearing assessment, number of no-show appointments, and
number of rescheduled appointments.

Aim 1 Analyses
All tests will be two-sided and will use a 5% statistical significance level. Analyses will be
conducted in SAS version 9.4 (SAS Institute, Cary, NC). Secondary analyses will utilize
adjusted significance levels or p-values to control for Type I errors due to multiple testing
using the method of Benjamini and Hochberg88 to control the false discovery rate, which
is an alternative to, and more powerful than, the conservative Bonferroni correction. The
primary effectiveness outcome is non-adherence rate, obtained with clinic-level data.
Analysis methods must account for any clustering within clinics (i.e., statistical
correlation among the binary non-adherence outcomes from patients within the same
clinic). Therefore, the primary intent-to-treat data analysis will utilize generalized
estimating equations (GEE) with corrected empirical standard errors in order to maintain
valid inference.89 We will fit the commonly utilized logistic regression model for the
analysis of binary outcomes arising from a stepped wedge design with clinics.90
Specifically, fixed effects for trial condition (primary interest) and time (nuisance
covariates needed to ensure a valid model) will be included in the model. Due to the use
of a stepped wedge design, clinics serve as their own controls, thus reducing the
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possibility of having a lack in balance between trial arms. For all analyses,
recommended statistical approaches will be utilized in the presence of missing data
(e.g., multiple imputation at the cluster level). Sensitivity analyses will be considered
and dictated by the type(s) of missing data.
Consistent with NIH requirements for rigor and transparency, secondary
analyses will include important sociodemographic variables (including sex of parents and
infants, parental age, parental educational attainment, household income, rural
residence) as covariates within the above model. Regarding additional secondary
outcomes of interest, we will explore associations among parent knowledge, selfefficacy, and barriers as related to (a) non-adherence, (b) time interval from birth to the
initial completed outpatient ABR, (c) number of no-show office visits, and (d) number of
rescheduled visits. Each of these analyses will utilize the same general GEE approach
to account for clustering of outcomes from participants in the same clinic. Depending on
the outcome type, a marginal (population average interpretation) generalized linear
model will be fit (i.e., a linear model for a continuous outcome and logistic model for a
binary outcome).

Aim 1 Power and Sample Size Calculations
The trial follows a stepped wedge design consisting of data collection from 10 clinics
over a 4.5 year period (see Figure 3 and Time Table in C.9). To optimize power while
also ensuring an adequate number of participants within each clinic for each time period,
steps will consist of 6-month periods. The number of clinics receiving PN will accumulate
over time as shown in Figure 3. Based on this design, using a two-sided test and a 5%
significance level, we will have greater than 90% power to detect a difference between
PN and standard of care conditions, assuming a clinically meaningful effect of PN in
reducing non-adherence rates from 25.9% to the CDC benchmark of 10%. This power
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calculation accounts for any clustering within clinics (i.e., statistical correlation among
the binary non-adherence outcomes from participants within the same cluster, as
measured by the coefficient of variation). With an extremely conservative estimate of 10
referred infants per clinic each period, and conducting a power calculation for the usual
range of coefficients of variation from 0.15 to 0.4,90 statistical power ranged from 0.91 to
0.96. Furthermore, with slightly larger cluster sizes of 15 referred infants per clinic each
period, power was at least 0.98 under all scenarios. With 500-600 newborns with failed
hearing screens referred to these clinics each year (see Figure 2 in C.4), we expect
actual power to be higher.

Aim 1 Potential Limitations and Alternatives
Recruitment: The volume of referrals for infant hearing may fluctuate and the timing of
such referrals may vary, which may impact recruitment. We will monitor this closely and
work with CCSHCN clinics’ scheduling staff to efficiently and effectively enroll all eligible
participants. Loss to Follow-up: Those who are non-adherent and lost to follow-up may
have been tested at another institution. Our intent-to-treat analyses will maintain those
participants in the study and we will assess their adherence using the EHDI database
and individual follow-up attempts for data collection purposes. Control Group: Due to
the study design, prior to rollout of PN, each clinic will be in a control condition and no
individual-level data will be collected. If further individual-level data is needed from the
control condition, we will consider recruiting participants from some of the clinics during
standard of care. Turnover of PNs: Each clinic will be assigned 3 PNs. These
navigators are not employed full-time in this study, thus, having a pool of navigators will
allow for flexibility in delivery of the navigation intervention based on the availability of
the navigator. Reimbursement of the navigators will be based on the number of
participants navigated during the study. In the case of turnover, we will seek to
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continually identify new candidates to serve as PNs within each clinic. If we are unable
to recruit or maintain a PN in a particular clinic then we will utilize the centralized PNs for
that clinic, regardless of randomized condition. We will pay the PNs per dyad navigated
to improve retention of PNs. Alternate Study Designs: Each design considered for this
project has limitations. For example, an RCT with individual randomization would add
significant complexity, increase the likelihood of contamination, and require additional
personnel and resources to identify and train PNs simultaneously in all ten clinics; a
traditional cluster-randomized trial would have many of the same practical and
complexity concerns. A typical crossover design would pose logistical and ethical
challenges because (1) PN would be rolled out to 5 clinics at the same time, and (2)
reverting to the control condition may be unacceptable. The stepped wedge design lends
itself well to the goals of hybrid effectiveness-implementation studies and allows
adequate time at multiple geographically dispersed clinics to identify and train PNs.
Finally, this design is ideal because all clinics eventually cross to the PN condition,
consistent with the preferences of our CCSHCN partners.
3.4.6. Aim 2 Methods: Explore associations among implementation factors,
implementation outcomes, and effectiveness outcomes.
Specific Aim 2 will investigate factors associated with implementation and effectiveness
outcomes across the 10 clinic sites. This aim is guided by the Consolidated Framework
for Implementation Research (CFIR),79 using implementation constructs and outcomes
recommended by Proctor et al.91 Sources of data for this aim will include process
records of PNs, clinic administrators, staff, and providers, and parent participants. The
rationale for the procedures and measures proposed in this aim is illustrated in FIGURE
3.3. To prepare for potential scale-up of PN, we must understand the
implementation-related factors and outcomes that will maximize its public health
impact. Consistent with CFIR, we will assess PN skill (knowledge and behaviors)
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FIGURE 3.3: Implementation Logic Model
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following completion of the PN curriculum, including intervention fidelity; PN
characteristics (including local vs. centralized); inner and outer setting clinic
characteristics; and four key implementation outcomes: adoption, recruitment/retention,
reach/penetration, and sustainability.

Aim 2 Study Sample & Recruitment
Patient Navigators: The PNs (N = 23: 3 PNs serving 5 clinics in the centralized PN
condition; 15 serving 5 clinics in the local PN condition; 5 back-ups) will be enrolled as
study participants as well to collect implementation data. PNs will be identified from an
existing pool of parents/patients who have requested to be involved in hearing
healthcare research and patient advocacy, maintained by the CCSHCN. During the
selection process, potential PNs will be informed by trained research staff of the purpose
of the study and will provide written informed consent to participate in study procedures.
Inclusion criteria include: 1) age 21 years or older, 2) able to speak and read English,
and 3) willing to complete the PN training curriculum and deliver PN. Local PNs will be
required to reside within 50 miles of their CCSHCN clinic; the centralized PN will be
required to reside within 50 miles of the University of Kentucky campus. At least one PN
per clinic must be bilingual (Spanish-English).
Clinic Administrators, Staff, and Providers: At each clinic, one administrator, one
staff member, and one hearing healthcare provider (N=30) will be invited to participate in
Aim 2. Inclusion criteria include: 1) age 18 years or older, 2) able to speak/read English.
Parent Participants: All parent participants recruited in Aim 1 (N=1120) will also provide
Aim 2 data during their baseline and post-test assessments. A subset of approximately
20 (dependent on saturation) parent participants will be recruited through purposive
sampling and invited to also complete qualitative key informant interviews during their
post-test assessment, after providing written informed consent. These parents will
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represent a combination of urban vs. rural communities, non-adherent vs. adherent
results, and receiving centralized vs. local PN.

Aim 2 Procedures
Patient Navigators: It is necessary to collect data regarding PN skill (knowledge and
behaviors) to assess factors that influence successful implementation. There 2 types of
navigators that are used during this study: 1) local navigators that live in close proximity
to the clinic where they are assisting patients, and 2) central navigators that are located
at the primary institution of the PI. The data to be collected will include measures of the
PN knowledge regarding infant hearing loss diagnosis and treatment recommendations,
PN behaviors in the intervention delivery, and PN characteristics (sociodemographic,
local versus central navigator, attitudes toward evidence-based interventions). Baseline
data collection from PNs will occur immediately following study enrollment and before
PN training, comprising both quantitative and qualitative measures administered by a
trained interviewer. At the conclusion of PN training, PNs will take an examination to
ensure comprehension of critical principles necessary for successful navigation. A score
>80% will be required to pass the training. PNs with less than a passing score will be
allowed to repeat relevant training elements and retake the examination one time; if the
examination is not passed on the second round, the PN will not be employed in this
study and a new PN will be identified. PN skill is a key implementation factor, thus, for
those who pass the examination and proceed to intervention delivery, this outcomes will
be assessed by measuring the following: PNs will (1) audio-record 10% of PN sessions
(with parent permission) to allow assessment of fidelity, (2) complete a PN fidelity
checklist59 following each PN session, and (3) maintain process logs detailing time,
travel, attendance, frequency and modes of contact with families, and other activities
and expenses associated with PN delivery. Approximately 6 months after completing PN
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training, PNs will be interviewed and complete post-test assessments, again
administered by a trained interviewer. PNs will be compensated $25 at baseline and
post-test for completing the battery of assessments. In each clinic, the PN intervention
will continue after the 6-month assessment time point until the end of the 2nd quarter of
year 5.
Clinic Administrators, Staff, and Providers: Approximately 6 months after crossing to
the PN condition, administrators, staff, and providers from each clinic will participate in
qualitative interviews and complete quantitative measures administered by a trained
interviewer. For key informant interviews, we develop and utilize a semi-structured open
question

interview

script

using

a

CFIR

interview

guide

tool,

(http://www.cfirguide.org/guide/app/index.html#/)92 for inner and outer settings for the
Commission clinics. These constructs will include patient needs and resources,
cosmopolitanism,

peer

pressure,

external

policy

and

incentives,

structural

characteristics, networks and communications, culture, implementation climate,
compatibility, relative priority, organizational incentives and rewards, goals and
feedback, learning climate, readiness for implementation, leadership engagement,
available

resources,

access

to

knowledge

and

information

(http://cfirguide.org/constructs.html).93 Research staff will contact all study candidates
and informed consent will be obtained. A trained interviewer will conduct these
interviews in-person with participants. Initial questions will be open-ended, and follow-up
probes will be used to prompt clarification and elaboration of answers. Interviewers also
will take field notes during and after each interview. These notes will focus on the tenor
of the discussion and the participants’ non-verbal presentation. These participants will be
compensated $25.
Parent Participants: At the Aim 1 post-test assessment (16 weeks post-birth), parents
will complete a PN satisfaction measure.75 Parents completing post-test measures will
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be compensated $20 under Aim 1. : At the Aim 1 post-test assessment (16 weeks postbirth), parents will complete a PN satisfaction measure.75 Selected parents (N =
approximately 20) will also complete a 1-hour semi-structured key informant interview
with a trained interviewer exploring parents’ experiences with the PN intervention. We
develop and utilize a semi-structured open question interview script using a CFIR
interview guide tool92 for characteristics of individuals. Related to patient navigation,
these constructs will include knowledge and beliefs about the intervention, self-efficacy,
individual stages of change, individual identification with organization, and other
personal attributes.93 Research staff will contact all study candidates and informed
consent will be obtained. A trained interviewer will conduct these interviews in-person
with participants. Initial questions will be open-ended, and follow-up probes will be used
to prompt clarification and elaboration of answers. Interviewers also will take field notes
during and after each interview. These notes will focus on the tenor of the discussion
and the participants’ non-verbal presentation. Parents completing post-test measures
will be compensated $20 under Aim 1, and parents also completing key informant
interviews will be compensated an additional $25.

Aim 2 Measures
All instruments and interviews will be administered in person by trained
interviewers. Implementation outcomes of interest for this study include adoption,
recruitment/retention, reach/penetration, and sustainability, as depicted in Figure 3.3.
Adoption per clinic will be measured using a binary indicator of whether the PN
intervention was delivered even once at each CCSHCN clinic; this variable will be
measured using PN process records. Recruitment/retention per clinic will be measured
using data from EHDI and PN process records: the number of parent-infant dyads
contacted, screened for eligibility, and enrolled will be tracked, as well as numbers of
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dyads lost to follow-up, with reasons recorded when known. Number of PN contacts with
each dyad will also be recorded. Reach/penetration per clinic will be measured with the
ratio of parent-infant dyads receiving any dose of the PN intervention to the number of all
potential parent-child dyads referred; the numerator will be obtained from PN process
records, while the denominator will be obtained from EHDI records. Sustainability per
clinic will be measured by assessing PN activity each month and recording how many
consecutive months (out of all months in which referrals for infant diagnostic testing
occurred following the 6-month assessment time point) the PN intervention is delivered.
Measures of CFIR implementation factors will include PN characteristics:
knowledge (post-training examination score); fidelity (fidelity checklist and research staffrated transcripts of PN audiotapes); sociodemographic characteristics (age, sex,
education, and previous related professional experience); attitude toward evidencebased interventions (Evidence-Based Practice Attitude Scale-50 (EBPAS-50)94); selfefficacy to deliver the PN intervention (Counselor Activity Self-Efficacy Scale
(CASES)95); and PN modality (centralized versus local). Other factors include inner
setting characteristics: number of full time employees employed at the clinic; clinic
patient population size; clinic staff/adminstrator/provider-completed measures of
communication, organizational culture, capacity, environmental supports and resources
(Organizational Readiness to Change Assessment (ORCA)96 and Program Sustainability
Assessment Tool (PSAT)97); and inner setting themes identified in key informant
interviews of clinic staff/administrators/providers. Finally, measures of outer setting
characteristics include: county population size; designation as Appalachian versus nonAppalachian county; rural versus urban; and number of competing service providers in
the county. All outer setting characteristics will be collected from existing data sources
(e.g., state and Census data, provider referral lists from referring hospitals). Outer
setting themes will also be identified in key informant interviews of clinic
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staff/administrators/providers. Parent satisfaction with the PN intervention will also be
measured as an implementation factor, using the Patient Navigation Satisfaction
Inventory75 administered at the post-test assessment. Measures for Aim 2 are based on
up-to-date reviews of available instrument repositories (Seattle Implementation
Research

Collaborative

(SIRC)

and

Grid-Enabled

Measures-Dissemination

&

Implementation (GEM-D&I)); however, measurement of implementation constructs is a
rapidly evolving field, and consensus on recommended quantitative measures for many
of these constructs is still in development.91,98 Characteristics of individuals are also key
implementation factors and these constructs will be assessed from parent interviews
regarding patient navigation.

Aim 2 Analyses
Because this is a type 2 hybrid effectiveness-implementation trial, most Aim 2
analyses are exploratory in nature and intended to inform potential scale-up and multistate evaluation of implementation of PN (if found to be effective in this trial). Aim 2
employs a convergent mixed-methods approach to interpret quantitative and qualitative
findings simultaneously.99 For all quantitative measures, we will obtain descriptive
statistics and conduct exploratory comparisons among the 10 clinics, with particular
attention to PN, inner, and outer setting characteristics that seem to be associated with
effectiveness and implementation outcomes. As in Aim 1, exploratory analyses of the
quantitative data described in C.6.c above will use marginal (population average
interpretation) generalized linear models (i.e., a linear model will be utilized for a
continuous outcome and a logistic model for a binary outcome). Analyses comparing
patient-level data between clinics will utilize the same general GEE approach described
in Aim 1 to account for clustering of outcomes in the same clinic.
Additionally, we will examine the effects of the implementation factor of PN
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modality (centralized versus local) on clinic-level non-adherence rates. We will use the
same modeling strategy described for the primary effectiveness outcome in Aim 1 (see
C.5.c), but the fixed effects for trial condition will be extended to account for three
conditions (standard of care, centralized PN, local PN) in this exploratory analysis.
For key informant interviews, CFIR constructs of interest, as described above,
will be used to categorize themes generated by the key informants regarding individual
characteristics of parents, inner clinic setting, and outer clinic setting factors affecting
implementation of the PN intervention in CCSHCN clinics across Kentucky. Digital
recordings of key informant interviews will be transcribed in full. Transcripts will be
compared to interview notes by the interviewer the PI. Facilitated by use of Atlas.ti,100
transcripts will be coded line-by-line. The qualitative research team will co-code the text,
develop an initial codebook for each CFIR theme (i.e., individual characteristics, inner
setting, and outer setting), and use concordant and discordant codes to refine and
develop final codebook versions. After both raters re-code the first transcripts, the results
will be analyzed for inter-rater reliability. If reliability does not reach or exceed 0.85, the
raters will re-examine concordant and discordant coding and revise codes and
definitions accordingly until consensus is achieved.101
After achieving adequate inter-rater reliability, the coding process will continue for
the rest of the transcriptions. Four randomly selected transcripts will be identified for
double-coding and evaluation of inter-rater reliability, followed by any needed
modifications and recoding to achieve adequate inter-rater reliability. Once initial topical
coding has been completed, 10% of the sample (i.e., 2 parents and 3 clinic
staff/administrators/ providers) will be invited to participate in a member-checking
process to determine whether additional data collection is necessary and to ensure valid
inferences are made through coding procedures.102 Participants involved in memberchecking will receive an additional $25 compensation for their time and effort. Following
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the member-checking process and any needed corrections to the codebooks and
coding, the investigative team will meet to review the results of the topical coding
process and develop a summative grid of themes emerging from the interviews.
The summative grid of themes will be considered with the quantitative results
describing implementation factors and outcomes in a series of investigator meetings
designed to integrate these findings. Interpretations will be discussed with all coinvestigators, and differences will be resolved through discussion and revisiting of
primary data. As recommended by Creswell and colleagues,99 the convergent mixedmethods design of Aim 2 will allow us to simultaneously consider quantitative and
qualitative data from multiple perspectives to contextualize and gain a more complete
understanding of key implementation factors linked with the effectiveness and
implementation outcomes of PN.

Aim 2 Power and Sample Size Calculations
Because Aim 2 is primarily exploratory, the sample sizes for this study are based
on power calculations for the primary effectiveness outcome in Aim 1. With only 10
clinics participating, we may not have adequate power to detect significant associations
among implementation factors and outcomes (e.g., adoption, sustainability). However,
we will have sufficient power to detect differences in the primary effectiveness outcome
(clinic-level non-adherence rate) by local vs. centralized PN compared to the standard of
care condition. Specifically, using a two-sided test, a 5% significance level, and assumed
non-adherence of 10% in either PN condition and 25.9% in standard of care, our
conservative power calculations suggest that with 5 clinics per PN condition we will have
statistical power ranging from 0.80 to 0.87 to compare local PN to control and
centralized PN to control. This particular implementation factor is modifiable and results
will inform both scale-up and future implementation studies. For our qualitative analyses,
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the numbers of parents, clinic staff, administrators, and providers planned for key
informant interviews are based on previous work and expectations regarding the number
of participants needed to attain saturation.103

Aim 2 Potential Limitations and Alternatives
As described under Aim 1, potential Aim 2 limitations include difficulties with
recruitment, loss to follow-up, and turnover of PNs. Our strategies to overcome these
roadblocks are the same as described under Aim 1. In Aim 2, however, each of these
roadblocks also relates directly to the implementation factors and outcomes under
investigation; thus, encountering these problems and exploring their causes (e.g., low
self-efficacy of PNs leading to turnover; low satisfaction of parents with PN leading to
drop-out) will actually inform our Aim 2 analyses and conclusions and allow us to identify
strategies to improve implementation of PN.

3.4.7. Aim 3 Methods: Determine cost-effectiveness of PN from the perspective
of third party payers
Specific Aim 3 involves incremental cost-effectiveness analyses in which net
costs and net effectiveness of the intervention will be compared with that of standard of
care for patients referred to CCSHCN clinics after a failed newborn hearing screen.
Hypotheses: (a) PN of either kind after a failed newborn hearing screen will be cost
effective compared to the standard of care from the perspective of third-party payers; (b)
Centralized PN will be as or more cost-effective than local PN. We will compare net
costs and effectiveness of each PN modality–centralized versus local–compared to
standard of care. Results will be expressed as a ratio of differences in observed costs to
differences observed outcomes. The perspective of this evaluation will be third party
payers.
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Aim 3 Measures
Costs: Both direct and indirect costs associated with PN will be included. Costs
associated with the initial newborn hearing screen will be excluded from analyses since
these costs are incurred for all infants regardless of outcomes. Direct costs include the
cost of: PN establishment (PN recruitment and training costs), program implementation
(office space, PN time, PN travel and tools, PN materials, staff turnover), parent time
and travel (travel to seek diagnostic or PN services, time spent receiving diagnostic
services), treatment costs (costs of a rescreen or diagnostic audiology appointment),
and non-adherence costs for the clinics (no-show appointments). Research activity costs
(e.g., data collection, human subject protection training of PNs) are not included.
Indirect costs include opportunity costs of time (e.g. loss of productivity/wages) for the
parent(s). Cost data will be collected and monitored annually throughout the study
period, for both the intervention and standard of care conditions. Unit program costs will
be documented as Aims 1 and 2 are implemented and sustained over the study period.
Unit costs of PN and parent participant travel will be estimated using the distance
between patient and clinic address/zip code multiplied by the standard GSA standard
mileage rate and adding any lodging expenses (if applicable). Unit costs of PN time will
be estimated using logs maintained by the PNs and applying the hourly PN pay rate.
Parent participant time will be estimated using the average wage rate for Kentucky
(estimated using average wage data from the Bureau of Labor Statistics (BLS)). Unit
treatment costs will be estimated using charge data from the CCSHCN, aggregated at
the clinic level. Unit costs of non-adherence will be based on costs of PN time not used
but spent (which may vary if services are centralized versus local) and staff costs
associated with rescheduling. Loss of productivity will be estimated using an estimate of
time away from work (calculated using driving distance) and lost wages for one parent,
using BLS average wage statistics.
77

Effectiveness: The measured outcome of effectiveness to which costs will be
compared is the proportion of individuals in each group who achieve diagnosis by 3
months of age. We will derive these outcome data using clinic-level non-adherence rates
reported monthly by EHDI, collected in Aim 1.

Aim 3 Analyses
The cost-effectiveness analysis will follow analytic procedures outlined by Muennig and
Bounthavong.104 We will estimate costs associated with an incremental change
(measured as an increase or decrease in percentage points) in effectiveness for each
PN modality compared to standard of care (prior to a clinic crossing to the PN condition).
FIGURE 3.4 illustrates the anticipated flow of events in the PN. Using effectiveness and
implementation data from Aims 1 and 2, we will apply probabilities and costs to each
terminal event outlined to model estimated cost-effectiveness for each outcome. The
analyses will be performed using TreeAge Pro software.105 Results will be reported as a
ratio of incremental cost to incremental effectiveness for each terminal event, comparing
costs and outcomes of each PN group to the standard of care group, and, separately. An
incremental cost effectiveness ratio (ICER) will be calculated for each alternative to
determine the relative difference in costs associated with a percentage change in
effectiveness for each alternative. The general ICER equation is: ICER =

(𝐶𝐶1−𝐶𝐶0)

, where:

(𝐸𝐸1−𝐸𝐸0)

C 1 = Costs associated with PN, PN centralized, PN local; C 0 = Costs associated with
standard of care; E 1 = Effectiveness (outcomes) associated with PN, PN centralized, PN
local; and E 0 = Effectiveness (outcomes) associated with standard of care. For any
alternative with positive incremental cost but negative incremental effectiveness, an
ICER is not meaningful and thus will not be calculated.
The calculated ICERs can be used to determine which alternative may produce
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FIGURE 3.4. Flowchart of Possible Events
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the best outcome without exceeding stakeholders’ threshold of willingness-to-pay. As
this threshold is generally unknown, results will be presented for alternative thresholds
and reported using cost-effectiveness acceptability curves to plot the probability of each
alternative being cost-effective in relation to different values of willingness-to-pay,
presented in dollars.106 In addition, we will use one-way sensitivity analyses to account
for uncertainty in our parameter estimates, including the number of participating families,
costs of implementation, and PN effectiveness. For each key parameter, the sensitivity
analysis will estimate the expected value of PN given changes in each parameter, using
the estimate derived from study data plus or minus 20 percent. The results of the
analysis will be prepared as technical documents for presentation to the Kentucky
Medicaid program and other third-party payers that make policy decisions regarding
covered services. The results of the sensitivity analyses will further assist payers in
determining interest and ability to reimburse for PN services.

Aim 3 Potential Limitations and Alternatives
If aim 1 does not demonstrate effectiveness of patient navigation to reduce nonadherence, then this could serve as a challenge for this cost-effectivenss aim. Even if
the intervention is not effective in the primary outcomes, this aim will still provide
valuable information because, according to a national taskforce for EHDI programs, all
states must develop and implement family support interventions.10 An assessment of
cost-effectiveness of PN will be useful to further develop more effective interventions. If
PN under either modality does not demonstrate cost-effectiveness, the study results
remain useful in terms of identifying target areas for potential cost reduction and as
guidance for others considering implementation of similar PN programs. Another
potential challenge in Aim 3 is accurate measurement of costs. The study requires
reliable data on PN implementation and treatment costs, and necessitates detailed
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monitoring throughout the study period. Despite the challenge of collecting these data,
all stakeholders in this PN program have committed to providing the cost data outlined.

3.5. RIGOR AND REPRODUCIBILITY
As described in the Significance section, no interventions have been shown to
reduce non-adherence to diagnostic testing in this population. Our preliminary data,
based on a well-designed RCT, suggests that the PN intervention could be very effective
in reducing non-adherence, but a larger effectiveness study is needed. Our selection of
the pragmatic stepped wedge design maximizes feasibility and will achieve robust and
unbiased results. The biological variable of sex of parents and infants is included in Aim
1 effectiveness analyses; sex of PNs will be assessed in Aim 2 assessment of PN
characteristics as implementation factors. To address reproducibility and transparency,
we will also publish our study protocol and provide detailed methods and results. We will
also share study data and systematically disseminate our results to stakeholders,
researchers, and practitioners, as described in the Resource Sharing Plan section.

3.6. IMPLICATIONS AND FUTURE DIRECTIONS
We seek to follow the time timeline outlined in FIGURE 3.5. This study is critical
to assess the effectiveness, implementation factors, and cost of PN to improve delivery
of infant hearing healthcare within a larger state-funded clinic environment. These data
will be used to inform health policy on state and national levels. If PN is found to be
effective in these settings, future research will investigate the implementation of PN into
multiple practice types (university-based, private, state-funded) in a multi-state trial.
Other directions include testing effects of PN on adherence to hearing healthcare
treatment. This research is the first of its kind in hearing healthcare, will be rapidly
translatable to practice, and will contribute to implementation science.
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FIGURE 3.5. Study Time Table
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APPENDIX 1
Newborn Hearing Parent Questionnaire (Entrance)
Please read each of the below questions and mark the box or boxes next to your
response. Your name and your child’s name will not be attached to any of your
responses. We ask the same parent to fill out this questionnaire each time.
Study ID:____________________________________
Date:______________________________________
Contact phone:______________________________
Consent Form signed 

Date: _______________

1. Which county do you live in? _______________________________
2. How long does it take you to drive to the University of Kentucky?
______________hour(s)

____________minutes

3. What is your gender?
 Male

 Female

4. How are you related to this child? (Please check one.)
 Mother
 Father
 Relative
 Friend
 Other (Please explain: ______________________________________)
5. What is your ethnicity?
 White/Caucasian
 Black/African American
 Hispanic /Latino
 Asian /Pacific Islander
 Native American/American Indian
 Other
6. When is your birthday? ________ (mm/dd/yyyy)

7. What is your marital status?
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 Single, never married
 Married/domestic partnership
 Widowed
 Divorced/Separated

8. How many children do you have? _____________

9. How many years of education have you completed?
 Less than Middle School
 Some High School
 Completed High School/GED
 Some college
 College
 Graduate Degree

10. What is your annual household income?
 >$10,000
 $10,000-20,000
 $20,000-30,000
 $30,000-60,000
 >$60,000
11. What is your current employment status?
 Employed for wages
 Self-employed
 Out of work and looking for work
 Out of work but not currently looking for work
 A homemaker
 A student
 Military
 Retired
 Unable to work/Disabled
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12.

Yes

No

Did you smoke or use tobacco while
pregnant?





Did you use alcohol while pregnant?





Did you use any illicit drugs or
prescription drugs not prescribed to you
while pregnant?





The following questions are about your child who did not pass the hearing screening
test given right after birth at the hospital.
13. What kind of health insurance does your child have? (Please check as many as
apply.)
 Medicaid
 K-Chip
 Private or HMO/PPO
 None
 Other (Please explain: ______________________________________)
14.
Yes

No

Does your child have an established
primary doctor (Doctor, Nurse Practitioner,
or Physician Assistant)?





Did someone in the hospital tell you that
your baby had a newborn hearing
screening test?





Were you told the results of your child’s
newborn hearing screening test?





Do you understand why your child had a
newborn hearing screening test?
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15. When were you told the results of the hearing screening test?
 Right after the screening test was finished
 Some time after the screening test was conducted, but before leaving the
hospital
 I was not told the results
 Other (Please explain: __________________________________)
16. What were you told when you were given the results of the newborn hearing
screening test?
(Please write your answer below):

17. Your child was recommended to have follow-up testing on the:
 Right ear
 Left ear
 Both ears
 I do not know
18. How important do you think it is to follow up for more testing of your child’s
hearing? (Please check one.)




Not at all
Important



A little
important

Pretty
important

19. Do you have anyone in your family with hearing loss?
 Yes

 No

 I do not know
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Extremely
important

Tell us which family members have hearing loss (Father, mother, brothers,
sisters…)
____________________________________________________________
20. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree































My home
responsibilities will
make it hard to follow-up
for my child’s hearing
testing.











My job responsibilities
will make it hard to
follow-up for my child’s
hearing testing.











My child’s health
insurance will make it
hard to follow-up for
hearing testing.
The distance to the
clinic will make it hard to
follow-up for my child’s
hearing testing.
Difficulty getting
appointments will make
it hard to follow-up for
my child’s hearing
testing.

Please write down any
other things that might
make it difficult to
follow-up for your
child’s hearing testing in
the space below:
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Yes

No

I do not
know

Do you believe that newborn hearing screening
is important?







Do you believe that the newborn hearing
screening results are accurate?













21.

Would you like help in attending follow-up
appointments for your child’s hearing from UK
Healthcare?

22. Please describe in what ways UK Healthcare could make this hearing testing
process easier for you. (Please answer in the space below):
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23. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
disagree

Disagree

Undecided

Agree

Strongly
Agree

I would like to talk with
my child’s primary
doctor about the hearing
test results.











I feel that there are
doctors in my area who
can test my child’s
hearing











I feel my family will
accept and support my
child, regardless of the
hearing tests results.











I feel uncomfortable
talking about my child’s
hearing to others.











I feel confident about
the steps that need to be
taken to check my
child’s hearing











I’m afraid about what the
future hearing testing
may show about my
child











I do not know what to
expect with regard to
future hearing testing











24. The latest a child born with hearing loss should be diagnosed with hearing
loss is:
 3 months after birth
 6 months after birth
 9 months after birth
 12 months after birth
25. A child born with hearing loss should have started treatment no later than:
 3 months after birth
 6 months after birth
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 9 months after birth
 12 months after birth
26. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

I am knowledgeable
about the testing
process for newborn
hearing health.











Finding out my child’s
hearing test result was
upsetting. (Leave blank
if you did not receive
the results)











Hearing is important for
a child’s social
relationships.









































Hearing is important for
a child’s school
performance.
Early intervention
services can help
families with children
who have hearing loss.
There is no health
treatment for newborn
hearing impairment.

Thank you for the time you have spent answering these questions. If there is
anything else that you would like to share with us— comments, complaints,
compliments, concerns, or questions— please use this page to do so.
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APPENDIX 2
Newborn Hearing Parent Questionnaire (Exit Interview)
Please read each of the below questions and mark the box or boxes next to your
response. Your name and your child’s name will not be attached to any of your
responses. We ask the same parent to fill out this questionnaire each time.
Study ID:______________________________
Date:_________________________________
Contact phone:______________________________

1. Which county do you live in? _______________________________
2. What is your sex?
 Male

 Female

3. When is your birthday? ________ (mm/dd/yyyy)

4. What is your current employment status?
 Employed for wages
 Self-employed
 Out of work and looking for work
 Out of work but not currently looking for work
 A homemaker
 A student
 Military
 Retired
 Unable to work/Disabled
5. How long does it take you to drive to the University of Kentucky?
______________hour(s)

_________________minutes

6. How do you normally travel to doctor appointments?
 Personal vehicle
 Family/Friends bring me
 Public transportation
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The following questions are about your child who did not pass the hearing screening
given right after birth at the hospital.
7. What kind of health insurance does your child have? (Please check as many as
apply.)
 Medicaid
 K-Chip
 Private or HMO/PPO
 None
 Other (Please explain: ______________________________________)
8. How are you related to this child? (Please check one.)
 Mother
 Father
 Relative
 Friend
 Other (Please explain: ______________________________________)
9. Did you understand why your child had a hearing screening in the newborn
nursery?
 Yes

 No

10. Did someone in the hospital tell you about your appointment today?
 Yes

 No

11. Do you understand why you child has a hearing test today?
 Yes

 No
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12. What were you told regarding the reasons for this appointment? (Please write
your answer below):

13.

Not at all
Important

A little
Important

Pretty
Extremely
Important Important

How important was the hearing
screening test that your child
received in the newborn
nursery?









How important do you feel it
was to follow up today for
testing of your child’s hearing?









14. Do you have anyone in your family with hearing loss?
 Yes
 No
 I do not know
Tell us which family members have hearing loss (Father, mother, brothers,
sisters…) ______________________________________________________
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15. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
Agree

Agree

Undecided

Disagree

Strongly
Disagree

My child’s health insurance
made it hard to follow-up for
hearing.











The distance to the clinic
made it hard to follow-up for
my child’s hearing.











Difficulty getting
appointments made it hard
to follow-up for my child’s
hearing.











My home responsibilities
made it hard to follow-up for
my child’s hearing.











My job responsibilities will
make it hard to follow-up for
my child’s hearing.











Please write down any other things that made it difficult to follow-up
for your child’s hearing in the space below:
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16. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree



















































I feel confident about the
steps that need to be
taken to check my child’s
hearing











I feel uncomfortable
talking about my child’s
hearing testing to others.











I have talked with my
child’s primary doctor
about the hearing
screening done in the
newborn nursery.
My child’s primary doctor
recommend follow-up
testing of my child’s
hearing.
I feel that there are
doctors in my area who
can test for and treat
hearing loss
I feel my family has been
supportive in the getting
my child’s hearing tested
I have talked with friends
and family about the
hearing screening done in
the newborn nursery.

17. Please tell us how difficult it would be to obtain the following services:
Extremely
difficult

Slightly
difficult

Not difficult

Readily
accessible

Audiologist (someone
who checks hearing)











Speech therapist
Primary doctor
(Doctor, Nurse
Practitioner, or
Physician Assistant)





















Ear, Nose, and
Throat doctor
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I don’t
Know

18. The latest a child born with hearing loss should be diagnosed with hearing
loss is:
 3 months after birth
 6 months after birth
 9 months after birth
 12 months after birth
19. A child born with hearing loss should have started treatment no later than:
 3 months after birth
 6 months after birth
 9 months after birth
 12 months after birth
20. Please read the following items and check the box for each one that shows
how much you agree or disagree with that statement.
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

Hearing is important for a
child’s social
relationships.











Hearing is important for a
child’s school
performance.











Early intervention services
can help families with
children with hearing loss.











21. Would you like more help to attend follow-up appointments for your child’s
hearing?
 Yes

 No

 Unsure
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22. Please answer the following questions regarding your experience
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree





























































I feel comfortable
providing information to
other parents about
newborn hearing loss and
the hearing testing











I would be interested in
helping other parents learn
about hearing loss and the
hearing screening
process.









I am more knowledgeable
about the testing process
for newborn hearing health
since I left the hospital
I understand how to
proceed with my infant’s
hearing care
I have been provided
adequate information and
resources regarding
newborn hearing loss
I am an integral part of my
child’s hearing healthcare
team
Finding out my child’s
hearing test result was
upsetting.
The help I received from
the UK Healthcare to get
my child’s hearing tested
was adequate
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23. Please describe in what way UK Healthcare could have made this hearing
process easier for you. (Please answer in the space below):

24. How difficult was the process of having your child’s hearing loss diagnosed?
(Please check one.)

Not at all
difficult





A little
difficult

Pretty
difficult


Extremely
difficult

Thank you for the time you have spent answering these questions.
If there is anything else that you would like to share with us— comments,
complaints, compliments, concerns, or questions. Please use the rest of this
page to do so.
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APPENDIX 3
Patient Navigator Interview Guide:
Phone Contact 1 (initially after discharge)
Let the participant know that we do record the phone conversation for review to
assess discussion and find better ways of helping families through navigation.
Greetings and Building Trust – Remind participant of the study and the definition
of a patient navigator and rapport building through asking about the participant
and newborn.
a. Study purpose: We would like to see if the support and educational tools from a
patient navigator are helpful in reducing barriers to hearing health for your child. You
were randomized to the patient navigator, so you will have weekly to every other week
phone calls until you come in for your child’s hearing test by an audiologist, or hearing
professional.
b. Patient navigator: A person who has interest in pediatric hearing health or has been
trained to provide support and give resources to parents of children who fail the newborn
hearing screening or who have hearing loss. This person will provide guidance and
follow up with you to answer any questions regarding your child’s condition.
2. Building rapport through asking about the participant and newborn
a. Tell me a little about yourself and your family.
b. How is your family adjusting to the newborn?
c. What are you fears or concerns about your infant’s hearing? the follow-up hearing
testing?
3. Has the baby seen the pediatrician? Did you speak to the doctor about the
newborn hearing screening? What were you told about the results?
4. Inquiry about the hearing test date and any questions related about
expectations for the visit
a. Give the participant the test date/time and let her/him know that she/he will be
contacted by the Audiology Department a day or two before the appointment. If he/she
has any additional questions related to the visit, she/he can contact Audiology directly or
contact the navigator.
b. Does the participant have an understanding of what to expect at the ABR (Auditory
Brainstem Response) test?
- Stickers that detect how well a baby is hearing are placed on the baby’s forehead
and behind the ears
- We hope that the baby will sleep during the test. If he or she does not sleep, you
may have to return for a follow up visit to get an accurate test. We do not perform
sedated ABRs. The baby can have a bottle or pacifier before the test, but once the test
has begun, those items will cause noise on the test and cannot be used.
- During the test the baby stays asleep in a parent’s lap and testing is done for about
20-30 minutes. If the baby wakes up, there will be a few minutes to try to get the baby
back to sleep.
- After the test, the audiologist will let you know the results of the test and whether or
not your baby needs to return for additional testing. Sometimes your baby may need to
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grow further to get an accurate test, so he or she may have to come back for further
testing.
4. Navigator reviews the standard of care recommendations: 1, 3, 6, 12 month
steps
a. Newborn Hearing Screening completed by 1 month (already completed!)
b. Diagnosis by 3 months by an hearing test called an ABR (Auditory Brainstem
Response) completed by an hearing professional called an audiologist. Primary care
doctors do not have the specialized equipment or the training to do this test in his or her
office.
c. If a child is diagnosed with hearing loss, he or she will have to have another ABR by
a different audiologist to determine a diagnosis. There is available assistance, but a
child should have hearing aids if needed or any beginning therapy starting before 6
months old.
d. If a child needs a cochlear implant, this should be done at about 12 months old.
5. Are there any community or UK resources that relate to your child health care
that we can provide to you at either follow up phone calls or give to you in person
when we see you in the Audiology Clinic?

Phone Contact 2 (follow up from first phone contact) at Week 2 or Week 3
Participant reminded that phone conversation will be recorded to assess the
discussion
1. Greetings and any questions that were discussed from the first phone call
2. Make sure the participant knows where to park and the clinic location
3. Review information from the last phone conversation and answer any
questions the parent may have since that last phone call.
4. Has the baby seen the pediatrician? Did you speak to the doctor about the
newborn hearing screening? What were you told about the results?
4. Inquiry about the hearing test date and any questions related about
expectations for the visit
a. Give the participant the test date/time and let her/him know that she/he will be
contacted by the Audiology Department a day or two before the appointment. If he/she
has any additional questions related to the visit, she/he can contact Audiology directly or
contact the navigator.
b. Does the participant have an understanding of what to expect at the ABR (Auditory
Brainstem Response) test?
- Stickers that detect how well a baby is hearing are placed on the baby’s forehead
and behind the ears
- We hope that the baby will sleep during the test. If he or she does not sleep, you
may have to return for a follow up visit to get an accurate test. We do not perform
sedated ABRs. The baby can have a bottle or pacifier before the test, but once the test
has begun, those items will cause noise on the test and cannot be used.
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- During the test the baby stays asleep in a parent’s lap and testing is done for about
20-30 minutes. If the baby wakes up, there will be a few minutes to try to get the baby
back to sleep.
- After the test, the audiologist will let you know the results of the test and whether or
not your baby needs to return for additional testing. Sometimes your baby may need to
grow further to get an accurate test, so he or she may have to come back for further
testing.
5. Give sleep deprivation instructions
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APPENDIX 4
Patient Navigator Satisfaction Questionnaire
Please read each of the below questions and mark the box or boxes next to your
response. Your name and your child’s name will not be attached to any of your
responses. We ask the same parent to fill out this questionnaire each time.
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

My navigator gives me
enough time











My navigator makes me feel
comfortable











My navigator is dependable











My navigator is courteous
and respectful to me











My navigator listens to my
problems











My navigator is easy to talk
to











My navigator cares about me
personally











My navigator figures out the
important issues in my
healthcare











My navigator is easy to
contact











Thank you for the time you have spent answering these questions.
If there is anything else that you would like to share with us about your experience
with the patient navigator, please use the back of this page to do so. Comments,
complaints, compliments, concerns, or questions are welcome.
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Vestibular Schwannoma and Meningioma. Childrens Tumor Foundation NF
Conference. Portland, OR. June 13-16, 2009.
Bush M, Burns S, Kulp S, Chen CS, Jacob A, Welling DB, Chang LS. Mutation
Analysis and In Vitro HDAC Inhibitor Treatment of Benign Human Meningioma
Cells. The Ohio State University Medical Center Research Day, Columbus, OH.
April 3, 2009.
Bush M, Jones R, Shinn J. Test-Retest Reliability of VEMPS. American Auditory
Society Meeting, Scottsdale, AZ. March 4-7, 2007
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2006

Bush M, Jones R, Musiek F & Shinn J. Auditory Brainstem Response and
Behavioral Testing in Acoustic Neuroma Detection. American Auditory Society
Meeting, Scottsdale, AZ. March 5-7, 2006

INVITED LECTURES
2016

2016

2016

2015
2015

2015
2015

2015

2015

2015
2015
2015

2014
2014
2014

2013
2013

Bush M, Barry P, Thomlinson B. “’But He Wears Hearing Aids!’ – A Primer on
Meeting the Holistic Needs of Children who are Hard of Hearing.” Systems of
Care Academy. Lexington, KY. June 8, 2016. (Panel Discussion)
Studts T, Bush M. Interdisciplinary Research with Children: Examples from
Biomedical and Behavioral Studies. University of Kentucky CCTS Clinical
Research Update. Lexington, KY. May 10, 2016.
Bush M. Bridging the Gaps: Assessing and Addressing Hearing Health
Disparities. Johns Hopkins University Center for Hearing and Balance Seminar
Series. Baltimore, MD. April 7, 2016.
Bush M. Hearing Loss and Cochlear Implantation. Kentucky Academy of
Physicians Assistants. Lexington, KY. November 5, 2015.
Bush M. Hearing Preservation in Cochlear Implantation. Hearing Loss
Association of America, Kentucky Chapter Annual Meeting, Louisville, KY.
September 12, 2015.
Bush M. Diseases of Balance and Equilibrium. Hearing Loss Association of
America, Kentucky Chapter Annual Meeting, Louisville, KY. September 12, 2015.
Bush M. Family Perceptions and Experiences with the Early Hearing Detection
and Intervention System in Rural Communities. National Center for Hearing
Assessment and Management Webinar. August 11, 2015.
http://www.infanthearing.org/resources_home/events/family-perceptions.html
Bush M. Bridging the Gaps: Assessing and Addressing Pediatric Rural Hearing
Healthcare Disparities. Kentucky Academy of Audiology Annual Meeting,
Lexington, KY. July 25, 2015.
Bush M. Not a Second to Lose! The Race for Auditory Development. Lexington
Hearing and Speech Center Little Peeps Symposium, Lexington, KY. April 18,
2015.
Bush M. Resident Quiz Bowl. Kentucky Society of Otolaryngology Annual
Meeting. Lexington, KY. April 18, 2015.
Bush M. Hearing Preservation in Cochlear Implantation. Kentucky Speech and
Hearing Association Annual Meeting, Lexington, KY. February 26, 2015.
Bush M. Bridging the Gaps: Assessment of Rural Pediatric Hearing Health
Disparities. American Academy of Audiology eAudiology session, February 11,
2015.
Bush M. An Update On Infant Hearing Loss And Diagnostic Testing. Family
Medicine Review, Lexington, KY. May 12, 2014.
Bush M. Why Can't I Hear? An Overview of Hearing Loss Causes. Hearing Loss
Association of Kentucky, Lexington Chapter, May 8, 2014.
Bush M. Bridging the Gaps: Assessing and Addressing Rural Pediatric Hearing
Health Disparities. Indiana University DeVault Research Symposium Keynote
Speaker. March 12, 2014.
Bush M. An Update On Infant Hearing Loss And Diagnostic Testing. Family
Medicine Review, Lexington, KY. November 4, 2013.
Bush M. An Expanding Gap: Addressing Rural Hearing Healthcare Disparities
and Delays. University of Kentucky Department of Otolaryngology 25th
Anniversary Alumni Symposium. October 19, 2013.
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2013

2013

2013
2013

2013
2013

2013
2012
2012

2012
2012
2012

2012
2012
2011

2011

2011
2011

2011

2011

Bush M. Hearing Preservation in Cochlear Implantation. Hearing Loss
Association of America, Kentucky Chapter Annual Meeting, Louisville, KY. July
19, 2013.
Bush M. Pediatric Congenital Hearing Loss in Appalachia: Assessing and
Addressing Diagnostic Delays. Hearing Loss Association of America, Kentucky
Chapter Annual Meeting, Louisville, KY. July 19, 2013.
Bush M. A Pediatrician’s Guide to Healthy Ears. Contemporary Pediatrics
Conference. Marriott Griffin Gate Resort, Lexington, KY. May 18, 2013.
Bush M. Hearing Preservation in Cochlear Implantation. Featured Session at the
American Academy of Audiology AudiologyNOW! Annual Meeting, Anaheim, CA.
April 6, 2013.
Bush M. Hearing Preservation in Cochlear Implantation. American Academy of
Audiology eAudiology Session. April 6, 2013.
Bush M. Diagnostic and Therapeutic Inequities in Appalachian Pediatric
Congenital Hearing Loss. Kentucky Speech and Hearing Association Annual
Meeting, Lexington, KY. February 28, 2013.
Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist.
American Academy of Audiology eAudiology session, February 12, 2013.
Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing
Loss Association of America, Kentucky (Bardstown) Chapter, October 22, 2012.
Bush M. Evaluation of Dizziness in the Primary Care Setting. Kentucky
Association of Physician Assistants Annual Meeting. Lexington, KY October 21,
2012.
Bush M. Horizon of Hope: Addressing Audiologic Barriers in East Africa. Heuser
Hearing Institute Grand Rounds, Louisville, KY. June 27, 2012.
Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing
Loss Association of Kentuckiana, Louisville Chapter, May 8, 2012.
Bush M. ENT Through the Lifespan: Caring for the Ear from Cradle to Grave.
The Kentucky Coalition of Nurse Practitioners and Nurse Widwives 24th Annual
Conference. Louisville, KY. April 18, 2012.
Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing
Loss Association of America, Kentucky (Lexington) Chapter, March 1, 2012.
Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist.
University of Louisville Division of Audiology Grand Rounds, February 20, 2012.
Bush M. Pediatric Neuroradiology and Clinical Implications for the Pediatric
Hearing Specialist. Ohio School Speech Pathology Educational Audiology
Coalition Fall Conference, Columbus, OH. October 23, 2011.
Bush M. Neuroradiology and Related 3D Neuroanatomy for the Audiologist.
Alabama Academy of Audiology Annual Meeting, Sandestin, FL. October 1,
2011.
Bush M. Pediatric Neuroradiology and Neuroanatomy for the Hearing Specialist.
Heuser Hearing Institute Grand Rounds, Louisville, KY. September 14, 2011.
Bush M. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy
for Vestibular Schwannomas and Meningiomas. The Ohio State University
Annual Saunders Symposium, Columbus, OH. June 24, 2011.
Bush M. Vestibular Schwannoma: Update on Current Therapies and Potential
Future Options. Kentucky Society of Otolaryngology Annual Meeting, Lexington,
KY, May 21, 2011.
Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the
Audiologist. Featured Session at the American Academy of Audiology Annual
Meeting, Chicago, IL. April 9, 2011.
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2011
2010

2009

Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist. Ohio
Academy of Audiology Annual Meeting, Columbus, OH. February 19, 2011.
Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the
Audiologist. Featured Session at the American Academy of Audiology Annual
Meeting, San Diego, CA. April 16, 2010.
Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the
Audiologist. Learning Lab at the American Academy of Audiology Annual
Meeting, Dallas, TX. April 1, 2009.

UNIVERSITY CURRICULUM/LECTURES
2016

Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and
Expanding Your Practice through Health Disparities Research. February 15,
2016.
2015 Bush M. Evaluation of Dizziness in the Primary Care Setting. University of
Kentucky Department of Internal Medicine Resident Lecture Series. October 20,
2015.
2015 Bush M, Course Director. University of Kentucky Department of Otolaryngology
– Head and Neck Surgery Grand Rounds Series. Ongoing lecture series given
every 4th Wednesday of the Month.
2015 Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and
Expanding Your Practice through Health Disparities Research. July 15, 2015.
2015 Bush M. Online Center for Hearing Health. CME modules for provider
education. http://www.cecentral.com/node/1169
2015 Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and
Expanding Your Practice through Health Disparities Research. April 6, 2015.
2015 Bush M, Co-Course Director. Resident Core Curriculum: Otology, Neurotology
and Cranial Base Surgery. University of Kentucky, Lexington, KY. March, 2015.
2015 Bush M. Physiology of Equilibrium and Hearing. University of Kentucky
Department of Neurology Resident Lecture Series. February 2, 2015.
2014 Bush M. Work-Life Balance: Is that even possible? Department of
Otolaryngology Professionalism Lecture Series. University of Kentucky,
Lexington, KY. November 5, 2014.
2014 Bush M, Course Director. Resident Core Curriculum: Otolaryngologic
Manifestations of Systemic Disease. University of Kentucky, Lexington, KY
2014 Bush M and Valentino J. Congenital Hearing Loss. 1st year medical student
Neuroanatomy/Neurophysiology Course. University of Kentucky, Lexington, KY.
April 14-15, 2014.
2014 Bush M. Research Design 102: Statistics for the Mathematically Challenged.
Department of Otolaryngology Lecture Series. University of Kentucky, Lexington,
KY. March 5, 2014.
2014 Bush M. Research Design 101: A Dummies Guide to Clinical Research.
Department of Otolaryngology Lecture Series. University of Kentucky, Lexington,
KY. February 5, 2014.
2013-14
Bush M, Clinical Otology: The Diagnosis and Management of Ear
Disease. 3rd year medical student lecture. University of Kentucky, Lexington, KY.
2013 Bush M and Valentino J. Evaluation of the Vestibular Patient. 1st year medical
student Neuroanatomy/Neurophysiology Course. University of Kentucky,
Lexington, KY. April 8, 2013.
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2013

Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery: The
Facial Nerve: The Mother of All Cranial Nerves. University of Kentucky,
Lexington, KY. March 27, 2013.
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery:
Lesions of the Lateral Skull Base. University of Kentucky, Lexington, KY. March
20, 2013.
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery:
Cochlear Implantation. University of Kentucky, Lexington, KY. March 13, 2013.
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery:
Approaches to the Skull Base. University of Kentucky, Lexington, KY. March 6,
2013.
2013 Bush M, Course Director. Resident Core Curriculum: Neurotology and Cranial
Base Surgery. University of Kentucky, Lexington, KY. March, 2013.
2013 Bush M. Resident Core Curriculum: Otology: Vestibular physiology and clinical
evaluation and management of dizzy patients. University of Kentucky, Lexington,
KY January 9, 2013.
2012-13 Bush M, Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd
year medical student lecture. University of Kentucky, Lexington, KY.
2012 Bush M. Management of Hearing Loss and Facial Nerve Injury in the Trauma
Patient. Inter-Disciplinary Trauma Conference, November 27, 2012.
2012 Bush M, Course Director. Resident Core Curriculum: Oral Board Preparation.
University of Kentucky, Lexington, KY
2012 Bush M. Neuroradiology and Clinical Implications for the Audiologist. University
of Louisville Division of Audiology Grand Rounds, Louisville, KY. February 20,
2012.
2011 Bush M. Neuroradiology of the Temporal Bone. University of Kentucky
Department of Otolaryngology. Lexington, KY. February 17, 2012.
2011-12 Bush M, Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd
year medical student lecture. University of Kentucky, Lexington, KY.
2011 Bush M, Course Director. Resident Core Curriculum: Otolaryngologic
Manifestations of Systemic Disease. University of Kentucky, Lexington, KY
2011 Bush M. Otology/Neurology Resident Core Curriculum: Facial Nerve: Anatomy
and Pathology. Resident lecture. The Ohio State University, Columbus, OH.
2011 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd
year medical student lecture. The Ohio State University, Columbus, OH.
2010 Bush M. Otology/Neurology Resident Core Curriculum: Otosclerosis. Resident
lecture. The Ohio State University, Columbus, OH.
2010 Bush M. Otology/Neurology Resident Core Curriculum: Surgical Approaches to
the Skull Base. Resident lecture. The Ohio State University, Columbus, OH.
2010 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd
year medical student lecture. The Ohio State University, Columbus, OH.
2009 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd
year medical student lecture. The Ohio State University, Columbus, OH.
2009 Bush M. Otology/Neurology Resident Core Curriculum: Temporal Bone Trauma.
Resident lecture. The Ohio State University, Columbus, OH.
2009 Bush M. Basics of Temporal Bone Anatomy and Dissection. Annual Resident
Temporal Bone Course. The Ohio State University, Columbus, OH.
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REGIONAL/NATIONAL COURSES
2013 Stryker Resident Temporal Bone Surgical Dissection Course. University of
Cincinnati, March 9, 2013. Co-Course Directors: Ravi Samy and Matthew Bush.

RESEARCH MENTORSHIP
Medical Students:
Anita Shanker 2016-present
• Helping Infants Get HEaring Resources: The HIGHER Patient
Navigator Trial
Whitney Powell 2016-present
• Understanding Adult Perspectives Regarding Hearing
Healthcare
Tianshi (“Mike”) Liu 2016-present
• Systematic review of the Effects of Cochlear Implants and
adjunctive rehabilitation therapy on language perception and
performance among Infants with Congenital CMV infection
Diana Bigler 2016-present
•

Assessment of disruptive behavioral problems in children with
hearing loss
• Systematic Review of Disruptive Behavioral Problems Among
Hearing Impaired Children
Kayla Williams 2016-present
• Understanding Adult Perspectives Regarding Hearing
Healthcare
Julie Johnson 2015-present
• Current Trends in Evaluation and Management of Acoustic
Neuromas
Kristen Burke 2015-present
• Systematic Review of Disruptive Behavioral Problems Among
Hearing Impaired Children
• Validation of Remote Cochlear Implantation Candidacy
Evaluations
Taylor Shackleford 2015-present
• Systematic review of Patient Navigation for underserved and
minority populations
• Promoting Early Diagnosis of Congenital Hearing Loss with
Patient Navigation
• Primary mentor on Physician Scientist Mentored
Research Fellowship
Vania Rashidi 2015-present
• Assessment of disruptive behavioral problems in children with
hearing loss
• Primary mentor on Physician Scientist Mentored
Research Fellowship
Stevie Maxwell 2015-present
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•

Assessment of long term outcomes for glomus jugulare
patients tumors treated with gamma knife radiation
Stephen Chan 2014-2015
• Hearing health and healthcare disparities in adult patients
• Primary mentor on Physician Scientist Mentored
Research Fellowship
Bryce Noblitt 2013-2015
• Analysis of cochlear implant rehabilitation barriers for rural
pediatric cochlear implant recipients
• Physician attitudes regarding pediatric hearing loss in rural
Kentucky
• Promoting Early Diagnosis of Congenital Hearing Loss with
Patient Navigation
• Primary mentor on Physician Scientist Mentored
Research Fellowship
Julia Elpers 2013-2014
• Parental attitudes and experiences regarding pediatric hearing
loss in rural Kentucky
• Primary mentor on Physician Scientist Mentored
Research Fellowship
David Alexander (MS3-4) 2012 – 2013
• Physician attitudes regarding pediatric hearing loss in rural
Kentucky
Mariel Osetinsky (MS2-4) 2011 – 2013
• Investigation of delay of hearing healthcare for children with
cochlear implants in Appalachia
• Primary mentor on Physician Scientist Mentored
Research Fellowship
Kristin Bianchi (MS2-4) 2011 – 2013
• Investigation of diagnostic challenges for children with severe
hearing loss in rural Kentucky
• Geospatial Scan Statistical Analysis of Patterns of Pediatric
Hearing Loss in Kentucky
Ashley Loan (MS2-4) 2012-2013
• Investigation of hearing healthcare and rehabilitative services
for children in Central Kentucky
William Dougherty (MS3-4) 2012-2013
• Assessment of vestibular rehabilitation practice patterns and
availability of care
• A case-series review of pediatric autoimmune inner ear
disease
Ashleigh Long (MS2-4) 2011-2013
• The clinical utility of magnetic spectroscopy in
cerebellopontine angle tumors
• The range of subjective symptoms in patients with normal pure
tone audiometry
• The Effect Operating Room Noise on Auditory Processing
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Undergraduate Students:
Nicholas Laureano 2016
•

Systematic Review of Disruptive Behavioral Problems Among
Hearing Impaired Children

Residents:
Christopher Bingcang (PGY4-5) 2011-2012
• The utility of monothermal caloric testing in screening for
vestibular dysfunction
Joshua Dixon (PGY3-5) 2011-2014
• The effect of middle ear effusion on cochlear implant function
German Fikhmann (PGY2-5) 2012 – 2015
• Preservation of low-frequency hearing in cochlear implantation
Justin Way (PGY4-5) 2012-2013
• Investigation of the effect of operating room noise on auditory
processing
Deann Roberts (PGY4-5) 2012-2013
• The clinical utility and cost-effectiveness of pre-operative
imaging studies in cochlear implantation
Brian Hixon (PGY3-4) 2014-Present
• Assessment of rural adult hearing healthcare disparities
• Systematic review of barriers to hearing healthcare
Caitlin Fiorillo (PGY2-3) 2014-Present
• Assessing and addressing disruptive behavioral problems in
children with hearing loss
Kyle Fletcher (PGY2) 2015-Present
• Validation of Remote Cochlear Implantation Candidacy
Evaluations
• Systematic review of the Effects of Cochlear Implants and
adjunctive rehabilitation therapy on language perception and
performance among Infants with Congenital CMV infection
Mark Ringstrom (PGY3-4) 2014-Present
• MRI spectroscopy in the evaluation of cranial base tumors
Andrew Ebelhar (PGY3-4) 2014-Present
• Preoperative Assessment of Round Window Anatomy for
Cochlear Implantation with Intention of Hearing Preservation
via Round Window Insertion
Mitch Dobberpuhl (PGY3) 2015-Present
• Multidisciplinary Assessment of Clinical Symptoms and
Treatment of Vestibular Migraines
• Current Trends in Evaluation and Management of Acoustic
Neuromas
Mike Kaufman 2016-present
• Validation of Remote Cochlear Implantation Candidacy
Evaluations
• Systematic review of Patient Navigation for underserved and
minority populations
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Audiology Doctoral Students:
Margaret Barnett (2015-2016)
• Perspectives of Primary Care Medical Providers Regarding
Adult Hearing Healthcare in the Rural Context
JOURNAL PUBLICATIONS
1. Chan S, Hixon B, Adkins M, Shinn J, Bush M. Rurality and Determinants of
Hearing Healthcare in Adult Hearing Aid Recipients. Laryngoscope. 2017. (epub)
2. Bush M, Thompson R, Irungu C, Ayugi J. The Role of Telemedicine in Auditory
Rehabilitation: A Systematic Review. Otology & Neurotology. 2016. 37(10): 14661474.
3. Barnett M, Hixon B, Okwiri N, Irungu C, Ayugi J, Thompson R, Shinn J, Bush M.
Factors Involved in Access and Utilization of Adult Hearing Healthcare: A
Systematic Review. Laryngoscope. 2016. Aug 22. Epub.
4. Hixon B, Chan S, Adkins M, Shinn J, Bush M. Timing and Impact of Hearing
5.Healthcare in Adult Cochlear Implant Recipients: A Rural-Urban Comparison.
Otology & Neurotology. 2016. 37(9):1320-4.
5. Dobberpuhl MR, Maxwell S, Feddock J, St Clair W, Bush M. Treatment
Outcomes for Single Modality Management of Glomus Jugulare Tumors with
Stereotactic Radiosurgery. Otology & Neurotology. 2016. 37(9):1406-10.
6. Shinn J, Long A, Rayle C, Bush M. Primary Auditory Symptoms in Patients with
Normal Peripheral Hearing Sensitivity: Redefining Hearing Loss. Hearing,
Balance and Communication. 2015. 14(1):44-49.
7. Elpers J, Lester C, Shinn J, Bush M. Rural Family Perceptions and Experiences
with Early Infant Hearing Detection and Intervention: A Qualitative Study. J
Community Health. 2016. 41:226-233. PMID: 26316007
8. Bush M, Dougherty W. Assessment of Vestibular Rehabilitation Therapy
Training and Practice Patterns. J Community Health. 2015. 40(4):802-7. PMID:
25700790
9. Bush M, Alexander D, Noblitt B, Lester C, Shinn J. Pediatric Hearing Healthcare
in Kentucky’s Appalachian Primary Care Setting. J Community Health. 2015.
40(4):762-8. PMID: 25672888
10. Dougherty W, Thatayatikom A, Bush M. Pediatric Autoimmune Inner Ear
Disease: A Case Series. Hearing, Balance and Communication. 2015. 13(1): 3239.
11. Bush M, Hardin B, Rayle C, Lester C, Studts C, Shinn J. Rural Barriers to Early
Diagnosis and Treatment of Infant Hearing Loss in Appalachia. Otology &
Neurotology 2015. 36(1): 93-98. PMID: 25325844
12. Bush M, Christian J, Bianchi K, Lester C, Schoenberg N. Targeting Regional
Pediatric Congenital Hearing Loss Using a Spatial Scan Statistic. Ear & Hearing.
2015. 36(2): 212-6. PMID: 25225918
13. Dixon J, Shinn J, Adkins M, Hardin B, Bush M. Middle Ear Disease and Cochlear
Implant Function: A Case Study. Hearing, Balance and Communication. 2014
Sept; 12(3): 155-158.
14. Bush M, Osetinsky M, Shinn J, Gal T, Fardo D, Schoenberg N. Assessment of
Appalachian Region Pediatric Hearing Healthcare Disparities and Delays.
Laryngoscope. 2014 Jul; 124(7):1713-7. PMID: 24402802 PMCID: PMC4069222
15. Bush M, Bianchi K, Lester C, Shinn J, Gal T, Fardo D, Schoenberg N. Delays in
Diagnosis of Congenital Hearing Loss in Rural Children. J Pediatr 2014;164:3937. PMID: 24183213. PMCID: PMC3946850.
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16. Roberts D, Bush M, Jones R. Adult Progressive Sensorineural Hearing Loss: Is
pre-operative imaging necessary prior to cochlear implantation. Otology &
Neurotology 2014 Feb;35(2):241-5. PMID: 24448283.
17. Bush M, Burton M, Loan A, Shinn J. Timing Discrepancies of Early Intervention
Hearing Services in Urban and Rural Cochlear Implant Recipients. Otology &
Neurotology. 2013. 34(9): 1630-5. PMID: 24136305 PMCID: PMC3830638
18. Way J, Long A, Weighing J, Ritchie R, Jones R, Bush M, Shinn J. The Effect of
Noise on Auditory Processing in the Operating Room. Journal of the American
College of Surgeons 2013. 216(5):933-8. PMID: 23518255.
19. Bush M, Bingcang C, Chang E, Fornwalt B, Rayle C, Gal TJ, Jones R, Shinn J.
Hot or Cold: Is Monothermal Caloric Testing Useful and Cost-Effective? Annals
of Otology, Rhinology, & Laryngology. 2013. 122(6): 412-416. PMID: 23837395
20. Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Senner V, Chen CS,
Jacob A, Welling DB, Chang LS. AR-42, a Pan-Histone Deacetylase Inhibitor,
Differentially Affects Cell-cycle Progression of Meningeal and Meningioma Cells
and Potently Inhibits Tumor Growth in a Quantifiable NF2-deficient Benign
Meningioma Model. Cancer Research. Jan 15, 2013. 73(2): 792-803. PMID:
23151902
21. Walz P, Bush M, Robinett Z, Kirsch C, Welling DB. 3D Volumetric Conformal
Analysis of Vestibular Schwannomas: Comparison of volumetric and linear
measurements for estimation of sporadic vestibular schwannoma growth.
Otolaryngology – Head and Neck Surgery. 2012 Oct; 147(4): 737-43. PMID:
22588731
22. Bush M, Oblinger J, Davletova S, Burns S, Chang LS, Welling DB, Jacob A.
Treatment of Vestibular Schwannoma Cells with ErbB Inhibitors. Otology &
Neurotology. 2012 Feb; 33(2):244-57. PMID: 22222570
23. Cipolla MJ, Iyer P, Dome C, Welling DB, Bush M. Modification and Comparison
of Minimally-Invasive Cochleostomy Techniques: A Pilot Study. Laryngoscope.
2012 May; 122(5): 1142-7. PMID: 22447373.
24. Jacob A, Oblinger J, Bush M, Brendel V, Santarelli G, Chaudhury AR, Kulp S, La
Perle KMD, Chen CS, Chang LS, Welling DB. Preclinical Validation of AR42, a
Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas.
Laryngoscope. 2012 Jan; 122(1):174-89. PMID: 22109824.
25. Bush M, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva E, Burns
S, Wheeler, Davis J, Yates C, Chaudhury A, Kulp S, Chen C, Chang L, Welling
D, Jacob A. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy
for Vestibular Schwannomas and Meningiomas. Neuro Oncology 2011 Sep.
13(9): 983-99. PMID: 21778190.
26. Bush M, Pritchett C, Packer M, Ray-Chaudhury, A, Jacob A.
Hemangioblastoma of the Cerebellopontine Angle. Archives of Otolaryngology –
Head and Neck Surgery. 2010 Jul; 136(7): 734-8. PMID: 20644074.
27. Bush M, Jones R, Shinn J. The Clinical Reliability of Vestibular Evoked
Myogenic Potentials. Ear, Nose, and Throat Journal 2010 Apr; 89(4): 170-6.
PMID: 20397145.
28. Shinn J, Bush M, Jones R. Correlation of Central Auditory Processing Deficits
and Vascular Loop Syndrome. Ear, Nose, and Throat Journal. 2009
Oct;88(10):E34-7. PMID: 19826989.
29. Bush M, Jones R, Givens C. The value of CT venography in the diagnosis of
jugular bulb diverticulum: A series of 3 cases. Ear, Nose, and Throat Journal.
2009 April; 88(4):E04. PMID: 19358118.
30. Bush M, Jones R, Shinn J. Auditory Brainstem Response Threshold Differences
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in Patients with Vestibular Schwannoma: A New Diagnostic Index. Ear, Nose,
and Throat Journal. 2008 Aug; 87(8):458-62. PMID: 18712694.
31. Bush M, Shinn J, Young AB, Jones R. Long-term Hearing Results in Gamma
Knife Radiosurgery for Acoustic Neuromas. Laryngoscope. 2008 Jun; 118(6):
1019-22. PMID: 18364592.
32. Bush M, Gupta S. Lilliputian Hallucinations and Marijuana Dependence in a
Bipolar Patient. The Jefferson Journal of Psychiatry. 2002. 17(1): 68-72.
BOOKS AND BOOK CHAPTERS
Bush M, Welling DB. Cerebellopontine Angle Tumors, in Head and Neck Surgery –
Otolaryngology, 5th Johnson JT and Rosen CA, eds. Philadelphia: Lippincott Williams
& Wilkins. 2013. ISBN: 9781609136020.
Bush M, Welling DB. Neurofibromatosis Type 2, in The Five Minute Neurology Consult,
2nd ed. Lynn DJ, Newton HB, Rae-Grant AD, eds. Philadelphia: Lippincott Williams &
Wilkins. 2012. ISBN: 9781451100129
Bush M. Diseases of the external and middle ear, in Disorders of the Auditory System,
Musiek F, Baran J, Shinn J, Jones R, eds. San Diego: Plural Pub. 2012.
Bush M. Diseases of the cochlea, in Disorders of the Auditory System, Musiek F, Baran
J, Shinn J, Jones R, eds. San Diego: Plural Pub. 2012.
CURRENT RESEARCH FUNDING
2/2016 – 2/2018

Advanced Bionics Sponsored Clinical Trial
Title: Implantation of the HiRes90K™ Advantage Cochlear Implant
with HiFocus™ Mid-Scala and Development of a Combined Electric
and Acoustic Stimulation Technology in Adults with Partial Deafness
($97,939)
Role: PI

3/2015 – 3/2018

NIH/NIDCD Career Development Award (1 K23 DC014074-01)
“Promoting Early Diagnosis of Congenital Hearing Loss through
Patient Navigation” ($685,149)
Role: PI

7/2011 – 7/2017

University of Kentucky College of Medicine Start-up Funds
($225,000)

COMPLETED RESEARCH FUNDING
2/2015 – 8/2016
University of Kentucky CCTS Junior Investigator Pilot Award
(UL1TR000117)
“Assessing and Addressing Disruptive Behavioral Problems in Children with Hearing
Loss” ($25,000)
Role: Co-PI
8/2014 – 7/2016
AAO-HNSF: Triological Society Career Development Award
“Promoting Early Diagnosis of Congenital Hearing Loss through Patient Navigation”
($40,000)
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Role: PI
11/2012 – 11/2015 NIH/NIDCD (1U24-DC012079-01) Resources for Mentorship of
Clinician Scientists in Hearing and Balance Disorders
Mentored research grant to support career development of early clinician scientists
7/2012 – 2/2015
NIH KL2 Award (8 KL2 TR000116-02)
“Bridging the Gaps: Assessment of Pediatric Hearing Loss in Appalachia”
10/2012 – 10/2014 NIH Health Disparities Loan Repayment Award
“Pediatric Hearing Loss in Rural Appalachia: Assessment of Successful Identification
and Timely Intervention.”
7/2009 – 12/2010
American Hearing Research Foundation Wiley H. Harrison
Grant AAO-HNS CORE grant, Principal Investigator
“In vitro and in vivo response to HDAC inhibitors by vestibular schwannomas”
($25,000).
INTERNATIONAL HUMANITARIAN EFFORTS
Development of the Sikiza Society, an international academic collaboration between
the University of Kentucky and the University of
Nairobi: http://www.entnet.org/content/humanitarian-efforts-map
• Call of Duty: Personal, Professional Merits of Humanitarian
Work. ENTtoday. June 5, 2016.
http://www.enttoday.org/article/call-duty-personalprofessional-merits-humanitarianwork/?elq_mid=10215&elq_cid=3437612
CURRENT RESEARCH INTERESTS
• Rural Hearing Health Disparities
• Disruptive behavioral problems in Children with Hearing Loss
• Hearing Preservation in Cochlear Implantation
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